web_fetch/041_recent_recruiting_trials-2

{
  "tool_name": "web_fetch",
  "tool_input": {
    "brief": "Phase 3 interventional recruiting studies started in past 14 days",
    "url": "https://clinicaltrials.gov/api/v2/studies?filter.advanced=%5BREDACTED%5D&query.term=%5BREDACTED%5D&pageSize=%5BREDACTED%5D&fields=%5BREDACTED%5D"
  },
  "dispatch_id": "toolu_01PuAp9TKJBZPGz2XUBroBih",
  "parent_dispatch_id": "",
  "handle": "",
  "panel_kind": "web_fetch"
}

{
  "tool_name": "web_fetch",
  "dispatch_id": "toolu_01PuAp9TKJBZPGz2XUBroBih",
  "status": "running",
  "result": null,
  "error": "",
  "elapsed": null,
  "fields": {
    "progress": {
      "message": "Phase 3 interventional recruiting studies started in past 14 days",
      "metadata": {
        "browser_chain": false,
        "url": "https://clinicaltrials.gov/api/v2/studies?filter.advanced=%5BREDACTED%5D&query.term=%5BREDACTED%5D&pageSize=%5BREDACTED%5D&fields=%5BREDACTED%5D"
      }
    },
    "status": "running",
    "updatedAt": 1789169490832
  }
}

{
  "tool_name": "web_fetch",
  "dispatch_id": "toolu_01PuAp9TKJBZPGz2XUBroBih",
  "status": "completed",
  "result": {
    "content": "{\"studies\":[\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07738172\",\"briefTitle\":\"Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung Cancer\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-08\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"National Taiwan University Hospital\"}},\"conditionsModule\":{\"conditions\":[\"Lung Neoplasms, Non-Small Cell Lung Cancer\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":154,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"PROCEDURE\",\"name\":\"Primary Tumor Resection\"},{\"type\":\"DRUG\",\"name\":\"Osimertinib\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"National Taiwan University Hospital\",\"city\":\"Taipei\",\"country\":\"Taiwan\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07640789\",\"briefTitle\":\"A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-08-28\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Sichuan Baili Pharmaceutical Co., Ltd.\"}},\"conditionsModule\":{\"conditions\":[\"Non-small Cell Lung Cancer Stage III\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":418,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"BL-B01D1\"},{\"type\":\"DRUG\",\"name\":\"Osimertinib\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Cancer Hospital of Shandong First Medical University\",\"city\":\"Jinan\",\"country\":\"China\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07686081\",\"briefTitle\":\"Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Vanda Pharmaceuticals\"}},\"conditionsModule\":{\"conditions\":[\"Ulcerative Colitis (UC)\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":150,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Ponesimod\"},{\"type\":\"DRUG\",\"name\":\"Placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Vanda Investigational Site\",\"city\":\"Chula Vista\",\"country\":\"United States\"},{\"facility\":\"Vanda Investigational Site\",\"city\":\"Nashville\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07564141\",\"briefTitle\":\"Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-08-28\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Genmab\"}},\"conditionsModule\":{\"conditions\":[\"Platinum-Sensitive Ovarian Cancer\",\"Ovarian Cancer\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":688,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"BIOLOGICAL\",\"name\":\"Rina-S\"},{\"type\":\"DRUG\",\"name\":\"Bevacizumab\"},{\"type\":\"DRUG\",\"name\":\"Carboplatin\"},{\"type\":\"DRUG\",\"name\":\"Gemcitabine\"},{\"type\":\"DRUG\",\"name\":\"Paclitaxel\"},{\"type\":\"DRUG\",\"name\":\"PLD\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Danbury Hospital\",\"city\":\"Danbury\",\"country\":\"United States\"},{\"facility\":\"ProHealth Care Inc\",\"city\":\"Waukesha\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07804186\",\"briefTitle\":\"Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"IDEAYA Biosciences\"}},\"conditionsModule\":{\"conditions\":[\"Uveal Melanoma\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":450,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Darovasertib\"},{\"type\":\"DRUG\",\"name\":\"Crizotinib (Xalkori)\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Princess Margaret Cancer Centre\",\"city\":\"Toronto\",\"country\":\"Canada\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07623161\",\"briefTitle\":\"A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Takeda\"}},\"conditionsModule\":{\"conditions\":[\"Myelofibrosis\",\"Anemia\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":324,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Placebo\"},{\"type\":\"DRUG\",\"name\":\"Elritercept\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Banner MD Anderson Cancer Center\",\"city\":\"Gilbert\",\"country\":\"United States\"},{\"facility\":\"Los Angeles Cancer Network\",\"city\":\"Glendale\",\"country\":\"United States\"},{\"facility\":\"Cancer and Blood Specialty Clinic\",\"city\":\"Whittier\",\"country\":\"United States\"},{\"facility\":\"MedStar Georgetown University Hospital\",\"city\":\"Washington D.C.\",\"country\":\"United States\"},{\"facility\":\"Advanced Research, LLC\",\"city\":\"Coral Springs\",\"country\":\"United States\"},{\"facility\":\"Bioresearch Partners\",\"city\":\"Miami\",\"country\":\"United States\"},{\"facility\":\"AdventHealth - Cancer Institute - Orlando\",\"city\":\"Orlando\",\"country\":\"United States\"},{\"facility\":\"Florida Clinical Trials Group\",\"city\":\"Tamarac\",\"country\":\"United States\"},{\"facility\":\"Moffit Cancer Center\",\"city\":\"Tampa\",\"country\":\"United States\"},{\"facility\":\"Emory University\",\"city\":\"Atlanta\",\"country\":\"United States\"},{\"facility\":\"Tufts Medical Center\",\"city\":\"Boston\",\"country\":\"United States\"},{\"facility\":\"Washington University School of Medicine\",\"city\":\"St Louis\",\"country\":\"United States\"},{\"facility\":\"St. Vincent Regional Hospital Cancer Centers\",\"city\":\"Billings\",\"country\":\"United States\"},{\"facility\":\"University of New Mexico Comprehensive Cancer Center\",\"city\":\"Albuquerque\",\"country\":\"United States\"},{\"facility\":\"Memorial Sloan Kettering Cancer Center\",\"city\":\"New York\",\"country\":\"United States\"},{\"facility\":\"Icahn School of Medicine at Mount Sinai\",\"city\":\"New York\",\"country\":\"United States\"},{\"facility\":\"Duke Blood Cancer Center\",\"city\":\"Durham\",\"country\":\"United States\"},{\"facility\":\"Novant Health\",\"city\":\"Winston-Salem\",\"country\":\"United States\"},{\"facility\":\"Cleveland Clinic\",\"city\":\"Cleveland\",\"country\":\"United States\"},{\"facility\":\"Oregon Health and Science University\",\"city\":\"Portland\",\"country\":\"United States\"},{\"facility\":\"Thomas Jefferson University\",\"city\":\"Philadelphia\",\"country\":\"United States\"},{\"facility\":\"University of Pittsburgh Medical Center\",\"city\":\"Pittsburgh\",\"country\":\"United States\"},{\"facility\":\"Allegheny Health Network Cancer Institute - West Penn Hospital Location\",\"city\":\"Pittsburgh\",\"country\":\"United States\"},{\"facility\":\"Medical University of South Carolina\",\"city\":\"Charleston\",\"country\":\"United States\"},{\"facility\":\"Vanderbilt-Ingram Cancer Center (VICC)-Nashville\",\"city\":\"Nashville\",\"country\":\"United States\"},{\"facility\":\"Baylor University Medical Center\",\"city\":\"Dallas\",\"country\":\"United States\"},{\"facility\":\"MD Anderson Cancer Center\",\"city\":\"Houston\",\"country\":\"United States\"},{\"facility\":\"The University of Utah-Huntsman Cancer Institute\",\"city\":\"Houston\",\"country\":\"United States\"},{\"facility\":\"LUMI Research\",\"city\":\"Houston\",\"country\":\"United States\"},{\"facility\":\"University of Washington\",\"city\":\"Seattle\",\"country\":\"United States\"},{\"facility\":\"Hospital Universitario Austral\",\"city\":\"Pilar\",\"country\":\"Argentina\"},{\"facility\":\"Swiss Medical Center Barrio Parque\",\"city\":\"Buenos Aires\",\"country\":\"Argentina\"},{\"facility\":\"Instituto Medico de la Fundacion Estudios Clinicos\",\"city\":\"Rosario\",\"country\":\"Argentina\"},{\"facility\":\"Hospital Privado de Rosario\",\"city\":\"Rosario\",\"country\":\"Argentina\"},{\"facility\":\"Hospital Aleman (HA) Deutsches Hospital\",\"city\":\"Buenos Aires\",\"country\":\"Argentina\"},{\"facility\":\"BRCR Global\",\"city\":\"Córdoba\",\"country\":\"Argentina\"},{\"facility\":\"Flinders Medical Centre\",\"city\":\"Bedford Park\",\"country\":\"Australia\"},{\"facility\":\"Mid North Coast Cancer Institute (MNCCI)\",\"city\":\"Coffs Harbour\",\"country\":\"Australia\"},{\"facility\":\"Tweed Valley Hospital\",\"city\":\"Cudgen\",\"country\":\"Australia\"},{\"facility\":\"South Eastern Sydney Local Health District\",\"city\":\"Kogarah\",\"country\":\"Australia\"},{\"facility\":\"Medizinische Universitat Wien (Medical University of Vienna - Austria)\",\"city\":\"Vienna\",\"country\":\"Austria\"},{\"facility\":\"Medizinische Universitat Innsbruck\",\"city\":\"Innsbruck\",\"country\":\"Austria\"},{\"facility\":\"Klinikum Wels-Grieskirchen\",\"city\":\"Wels\",\"country\":\"Austria\"},{\"facility\":\"Ordensklinikum Linz Elisabethinen\",\"city\":\"Linz\",\"country\":\"Austria\"},{\"facility\":\"Centre Hospitalier Jolimont-Lobbes\",\"city\":\"La Louvière\",\"country\":\"Belgium\"},{\"facility\":\"UZ Leuven\",\"city\":\"Leuven\",\"country\":\"Belgium\"},{\"facility\":\"AZ Delta\",\"city\":\"Roeselare\",\"country\":\"Belgium\"},{\"facility\":\"Ziekenhuis aan de Stroom-Cadix\",\"city\":\"Antwerp\",\"country\":\"Belgium\"},{\"facility\":\"CHU Namur Site Mont Godinne\",\"city\":\"Yvoir\",\"country\":\"Belgium\"},{\"facility\":\"Centro de Ensino, Pesquisa e Inovacao do Hospital Sao Lucas (CEPIN HSL RJ / Rede Americas)\",\"city\":\"Rio de Janeiro\",\"country\":\"Brazil\"},{\"facility\":\"Porto Alegre Clinical Hospital (HCPA)\",\"city\":\"Porto Alegre\",\"country\":\"Brazil\"},{\"facility\":\"Hospital Mae De Deus - Integrated Oncology Center\",\"city\":\"Porto Alegre\",\"country\":\"Brazil\"},{\"facility\":\"Hospital Sao Lucas da PUCRS\",\"city\":\"Porto Alegre\",\"country\":\"Brazil\"},{\"facility\":\"Grupo Elora Pesquisa Clinica\",\"city\":\"Florianópolis\",\"country\":\"Brazil\"},{\"facility\":\"Centro de Hematologia e Oncologia (CHO)\",\"city\":\"Joinville\",\"country\":\"Brazil\"},{\"facility\":\"Hospital Amaral Carvalho (HAC)\",\"city\":\"Jaú\",\"country\":\"Brazil\"},{\"facility\":\"Portuguese Charity of Sao Paulo\",\"city\":\"São Paulo\",\"country\":\"Brazil\"},{\"facility\":\"UMHAT 'Dr. Georgi Stranski', EAD\",\"city\":\"Pleven\",\"country\":\"Bulgaria\"},{\"facility\":\"Dr. Pencho Georgiev - Outpatient Center\",\"city\":\"Plovdiv\",\"country\":\"Bulgaria\"},{\"facility\":\"UMHAT Sv. Ivan Rilski\",\"city\":\"Sofia\",\"country\":\"Bulgaria\"},{\"facility\":\"Specialized Hospital for Active Treatment of Haematological Diseases - Sofia\",\"city\":\"Sofia\",\"country\":\"Bulgaria\"},{\"facility\":\"Juravinski Cancer Centre\",\"city\":\"Hamilton\",\"country\":\"Canada\"},{\"facility\":\"Princess Margaret Cancer Centre\",\"city\":\"Toronto\",\"country\":\"Canada\"},{\"facility\":\"Jewish General Hospital\",\"city\":\"Montreal\",\"country\":\"Canada\"},{\"facility\":\"McGill University Health Center\",\"city\":\"Montreal\",\"country\":\"Canada\"},{\"facility\":\"Hospital Cliniico Regional de Concepcion Dr\",\"city\":\"Concepción\",\"country\":\"Chile\"},{\"facility\":\"IC La Serena Research\",\"city\":\"La Serena\",\"country\":\"Chile\"},{\"facility\":\"Icegclinic\",\"city\":\"Santiago\",\"country\":\"Chile\"},{\"facility\":\"Immunocel\",\"city\":\"Las Condes\",\"country\":\"Chile\"},{\"facility\":\"Centro de Oncologia de Precision\",\"city\":\"Santiago\",\"country\":\"Chile\"},{\"facility\":\"Hospital Pablo Tobon Uribe\",\"city\":\"Medellín\",\"country\":\"Colombia\"},{\"facility\":\"Clinica General del Norte De Barranquilla\",\"city\":\"Barranquilla\",\"country\":\"Colombia\"},{\"facility\":\"Los Cobos Medical Center\",\"city\":\"Bogotá\",\"country\":\"Colombia\"},{\"facility\":\"Funcacion santa Fe De Bogota\",\"city\":\"Bogota\",\"country\":\"Colombia\"},{\"facility\":\"Masaryk University Hospital Brno, Department of Internal Medicine, Hematology and Oncology\",\"city\":\"Brno\",\"country\":\"Czechia\"},{\"facility\":\"Fakultni nemocnice Hradec Kralove\",\"city\":\"Hradec Králové\",\"country\":\"Czechia\"},{\"facility\":\"Vseobecna fakultni nemocnice Praha\",\"city\":\"Prague\",\"country\":\"Czechia\"},{\"facility\":\"Fakultni nemocnice Kralovske Vinohrady\",\"city\":\"Prague\",\"country\":\"Czechia\"},{\"facility\":\"CHU de Nice\",\"city\":\"Nice\",\"country\":\"France\"},{\"facility\":\"Centre Hospitalier Lyon Sud\",\"city\":\"Pierre-Bénite\",\"country\":\"France\"},{\"facility\":\"CHU de Strasbourg\",\"city\":\"Strasbourg\",\"country\":\"France\"},{\"facility\":\"Institut Paoli Calmettes\",\"city\":\"Marseille\",\"country\":\"France\"},{\"facility\":\"Centre Hospitalier Regional Universitaire Brest Hopital Morvan\",\"city\":\"Brest\",\"country\":\"France\"},{\"facility\":\"CHU de Bordeaux\",\"city\":\"Pessac\",\"country\":\"France\"},{\"facility\":\"Centre Hospitalier Regional Universitaire de Lille\",\"city\":\"Lille\",\"country\":\"France\"},{\"facility\":\"Assistance Publique Hopitaux de Paris\",\"city\":\"Paris\",\"country\":\"France\"},{\"facility\":\"CHU de Poitiers\",\"city\":\"Poitiers\",\"country\":\"France\"},{\"facility\":\"Universitaetsklinikum Freiburg\",\"city\":\"Freiburg im Breisgau\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsklinikum Heidelberg (UKHD)\",\"city\":\"Heidelberg\",\"country\":\"Germany\"},{\"facility\":\"Kliniken Ostalb\",\"city\":\"Mutlangen\",\"country\":\"Germany\"},{\"facility\":\"Muehlenkreiskliniken AoeR-Johannes Wesling Klinikum Minden - Universitaetsklinik fuer Neurologie und Neurogeriatrie\",\"city\":\"Minden\",\"country\":\"Germany\"},{\"facility\":\"Institut fur Versorgungsforschung in der Onkologie GbR\",\"city\":\"Koblenz\",\"country\":\"Germany\"},{\"facility\":\"Klinikum Chemnitz GmbH\",\"city\":\"Chemnitz\",\"country\":\"Germany\"},{\"facility\":\"University Hospital Halle (Saale)\",\"city\":\"Halle\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsklinikum Jena\",\"city\":\"Jena\",\"country\":\"Germany\"},{\"facility\":\"Praxis am Volkspark\",\"city\":\"Berlin\",\"country\":\"Germany\"},{\"facility\":\"Olympion General Clinic & Rehabilitation Center\",\"city\":\"Pátrai\",\"country\":\"Greece\"},{\"facility\":\"Laiko General Hospital of Athens\",\"city\":\"Athens\",\"country\":\"Greece\"},{\"facility\":\"General Hospital\",\"city\":\"Athens\",\"country\":\"Greece\"},{\"facility\":\"Alexandra General Hospital of Athens\",\"city\":\"Athens\",\"country\":\"Greece\"},{\"facility\":\"University of Crete\",\"city\":\"Heraklion\",\"country\":\"Greece\"},{\"facility\":\"Ippokrateion Hospital of Thessaloniki\",\"city\":\"Thessaloniki\",\"country\":\"Greece\"},{\"facility\":\"Debreceni Egyetem Klinikai Kozpont Belgyogyaszati Klinika\",\"city\":\"Debrecen\",\"country\":\"Hungary\"},{\"facility\":\"Komarom-Esztergom Varmegyei Szent Borbala Korhaz\",\"city\":\"Tatabánya\",\"country\":\"Hungary\"},{\"facility\":\"Medanta- The Medicity- Gurugram\",\"city\":\"Gurgaon\",\"country\":\"India\"},{\"facility\":\"Amrita Institute of Medical Sciences\",\"city\":\"Kochi\",\"country\":\"India\"},{\"facility\":\"Regional cancer Centre\",\"city\":\"Thiruvananthapuram\",\"country\":\"India\"},{\"facility\":\"Sahyadri Super Speciality Hospital Deccan\",\"city\":\"Pune\",\"country\":\"India\"},{\"facility\":\"All India Institute of Medical Science\",\"city\":\"New Delhi\",\"country\":\"India\"},{\"facility\":\"Rajiv Gandhi Cancer Institute and Research Centre\",\"city\":\"Rohini\",\"country\":\"India\"},{\"facility\":\"Apollo Specialty Hospitals\",\"city\":\"Chennai\",\"country\":\"India\"},{\"facility\":\"Apollo Hospital Hyderabad\",\"city\":\"Hyderabad\",\"country\":\"India\"},{\"facility\":\"Tata Medical Center, Kolkata\",\"city\":\"Kolkata\",\"country\":\"India\"},{\"facility\":\"Max Super Specialty Hospital\",\"city\":\"Delhi\",\"country\":\"India\"},{\"facility\":\"Cork University Hospital\",\"city\":\"Cork\",\"country\":\"Ireland\"},{\"facility\":\"St James's Hospital\",\"city\":\"Dublin\",\"country\":\"Ireland\"},{\"facility\":\"Mater Misericordiae University Hospital\",\"city\":\"Dublin\",\"country\":\"Ireland\"},{\"facility\":\"University Hospital Galway\",\"city\":\"Galway\",\"country\":\"Ireland\"},{\"facility\":\"Rambam Health Care Campus\",\"city\":\"Haifa\",\"country\":\"Israel\"},{\"facility\":\"The Tel Aviv Sourasky Medical Center\",\"city\":\"Tel Aviv\",\"country\":\"Israel\"},{\"facility\":\"Carmel Medical Center\",\"city\":\"Haifa\",\"country\":\"Israel\"},{\"facility\":\"Hadassah Medical Organization, Hadassah Medical Center, Ein-\",\"city\":\"Jerusalem\",\"country\":\"Israel\"},{\"facility\":\"Rabin Medical Center\",\"city\":\"Petah Tikva\",\"country\":\"Israel\"},{\"facility\":\"IRCCS - AOU di Bologna - Sant Orsola Malpighi\",\"city\":\"Bologna\",\"country\":\"Italy\"},{\"facility\":\"Universitaria di Ferrara Azienda Ospedaliero\",\"city\":\"Cona\",\"country\":\"Italy\"},{\"facility\":\"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST S.r.l\",\"city\":\"Meldola\",\"country\":\"Italy\"},{\"facility\":\"Universita degli Studi di Roma La Sapienza - Umberto I Policlinico di Roma\",\"city\":\"Rome\",\"country\":\"Italy\"},{\"facility\":\"Ospedale S Eugenio\",\"city\":\"Rome\",\"country\":\"Italy\"},{\"facility\":\"Fondazione Irccs Ca' Granda Ospedale Maggioe Policlinico Di Milano\",\"city\":\"Milan\",\"country\":\"Italy\"},{\"facility\":\"Fondazione Policlinico Universitario Agostino Gemelli IRCCS\",\"city\":\"Rome\",\"country\":\"Italy\"},{\"facility\":\"Azienda Ospedaliero-Universitaria delle Marche; SOD Clinica Medica\",\"city\":\"Ancona\",\"country\":\"Italy\"},{\"facility\":\"Policlinico Universitario di Catania\",\"city\":\"Catania\",\"country\":\"Italy\"},{\"facility\":\"Azienda Ospedaliera Universitaria Careggi\",\"city\":\"Florence\",\"country\":\"Italy\"},{\"facility\":\"AOU Citta della Salute e della Scienza di Torino\",\"city\":\"Torino\",\"country\":\"Italy\"},{\"facility\":\"Azienda Sanitaria Universitaria Friuli Centrale\",\"city\":\"Udine\",\"country\":\"Italy\"},{\"facility\":\"Chiba Cancer Center\",\"city\":\"Chiba\",\"country\":\"Japan\"},{\"facility\":\"Ehime University Hospital\",\"city\":\"Toon-shi\",\"country\":\"Japan\"},{\"facility\":\"Kobe City Medical Center General Hospital\",\"city\":\"Kobe\",\"country\":\"Japan\"},{\"facility\":\"Hitachi General Hospital\",\"city\":\"Hitachi\",\"country\":\"Japan\"},{\"facility\":\"Mie University Hospital\",\"city\":\"Tsu\",\"country\":\"Japan\"},{\"facility\":\"University of Miyazaki Hospital\",\"city\":\"Miyazaki\",\"country\":\"Japan\"},{\"facility\":\"Tokyo Metropolitan Komagome Hospital\",\"city\":\"Bunkyo-Ku\",\"country\":\"Japan\"},{\"facility\":\"University of Yamanashi Hospital\",\"city\":\"Chuo-shi\",\"country\":\"Japan\"},{\"facility\":\"University Malaya Medical Centre\",\"city\":\"Kuala Lumpur\",\"country\":\"Malaysia\"},{\"facility\":\"Hospital Pulau Pinang\",\"city\":\"George Town\",\"country\":\"Malaysia\"},{\"facility\":\"Hospital Queen Elizabeth\",\"city\":\"Kota Kinabalu\",\"country\":\"Malaysia\"},{\"facility\":\"Hospital Ampang\",\"city\":\"Ampang\",\"country\":\"Malaysia\"},{\"facility\":\"Hematologica Alta Especialidad S.C.\",\"city\":\"Huixquilucan\",\"country\":\"Mexico\"},{\"facility\":\"Universidad Autonoma de Nuevo Leon\",\"city\":\"Monterrey\",\"country\":\"Mexico\"},{\"facility\":\"OSMO - Oaxaca Site Management Organization S.C\",\"city\":\"Oaxaca City\",\"country\":\"Mexico\"},{\"facility\":\"Pratia Poznan\",\"city\":\"Poznan\",\"country\":\"Poland\"},{\"facility\":\"Wojewodzki Szpital Zespolony Im L Rydygiera\",\"city\":\"Torun\",\"country\":\"Poland\"},{\"facility\":\"MTZ Clinical Research Powered by PRATIA\",\"city\":\"Warsaw\",\"country\":\"Poland\"},{\"facility\":\"Zespol Szpitali Miejskich w Chorzowie\",\"city\":\"Chorzów\",\"country\":\"Poland\"},{\"facility\":\"Pratia Oncology Katowice\",\"city\":\"Katowice\",\"country\":\"Poland\"},{\"facility\":\"Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi, Oddzial Hematologii\",\"city\":\"Lodz\",\"country\":\"Poland\"},{\"facility\":\"Institutul Oncologic Prof. Dr. Ion Chiricuta\",\"city\":\"Cluj-Napoca\",\"country\":\"Romania\"},{\"facility\":\"Spitalul Municipal Filantropia Craiova\",\"city\":\"Craiova\",\"country\":\"Romania\"},{\"facility\":\"Colentina Clinical Hospital\",\"city\":\"Bucharest\",\"country\":\"Romania\"},{\"facility\":\"Spitalul Clinic Municipal de Urgenta Timisoara\",\"city\":\"Timișoara\",\"country\":\"Romania\"},{\"facility\":\"King Faisal Specialist Hospital & Research Centre Riyadh\",\"city\":\"Riyadh\",\"country\":\"Saudi Arabia\"},{\"facility\":\"King Khalid University Hospital\",\"city\":\"Riyadh\",\"country\":\"Saudi Arabia\"},{\"facility\":\"Samsung Medical Center\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Seoul National University Bundang Hospital\",\"city\":\"Seongnam-si\",\"country\":\"South Korea\"},{\"facility\":\"Korea University Anam Hospital\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Soon Chun Hyang University Hospital Seoul\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Daegu Catholic University Medical Center\",\"city\":\"Daegu\",\"country\":\"South Korea\"},{\"facility\":\"The Catholic University of Korea\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Seoul National University Hospital\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Institut Catala d'Oncologia\",\"city\":\"Badalona\",\"country\":\"Spain\"},{\"facility\":\"Institut Catala d'Oncologia Hospital Duran y Renals\",\"city\":\"L'Hospitalet de Llobregat\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario de Gran Canaria Doctor Negrin\",\"city\":\"Las Palmas de Gran Canaria\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Virgen de la Victoria\",\"city\":\"Málaga\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitari Vall d'Hebron\",\"city\":\"Barcelona\",\"country\":\"Spain\"},{\"facility\":\"Hospital Ramon Y Cajal\",\"city\":\"Madrid\",\"country\":\"Spain\"},{\"facility\":\"Universidad de Salamanca - Hospital Universitario de Salamanca\",\"city\":\"Salamanca\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitari i Politecnic La Fe\",\"city\":\"Valencia\",\"country\":\"Spain\"},{\"facility\":\"Orebro University Hospital\",\"city\":\"Örebro\",\"country\":\"Sweden\"},{\"facility\":\"Karolinska University Hospital\",\"city\":\"Stockholm\",\"country\":\"Sweden\"},{\"facility\":\"Taipei Veterans General Hospital\",\"city\":\"Taipei\",\"country\":\"Taiwan\"},{\"facility\":\"National Taiwan University Hospital\",\"city\":\"Taipei\",\"country\":\"Taiwan\"},{\"facility\":\"Kaohsiung Medical University Hospital\",\"city\":\"Kaohsiung City\",\"country\":\"Taiwan\"},{\"facility\":\"Taichung Veterans General Hospital\",\"city\":\"Taichung\",\"country\":\"Taiwan\"},{\"facility\":\"National Cheng Kung University Hospital\",\"city\":\"Tainan\",\"country\":\"Taiwan\"},{\"facility\":\"Ankara Bilkent City Hospital\",\"city\":\"Çankaya\",\"country\":\"Turkey (Türkiye)\"},{\"facility\":\"VM Medical Park Mersin Hospital\",\"city\":\"Mersin\",\"country\":\"Turkey (Türkiye)\"},{\"facility\":\"Istanbul University-CerrahpaAYa, CerrahpaAYa Faculty of Medicine\",\"city\":\"Istanbul\",\"country\":\"Turkey (Türkiye)\"},{\"facility\":\"Istanbul Florence Nightingale Hospital\",\"city\":\"Istanbul\",\"country\":\"Turkey (Türkiye)\"},{\"facility\":\"United Lincolnshire Teaching Hospitals NHS Trust\",\"city\":\"Lincoln\",\"country\":\"United Kingdom\"},{\"facility\":\"University Hospital of Leicester NHS\",\"city\":\"Leicester\",\"country\":\"United Kingdom\"},{\"facility\":\"Imperial College Healthcare NHS Trust\",\"city\":\"London\",\"country\":\"United Kingdom\"},{\"facility\":\"Sunderland and South Tyneside NHS Foundation Trust\",\"city\":\"Sunderland\",\"country\":\"United Kingdom\"},{\"facility\":\"Birmingham Heartlands Hospital\",\"city\":\"Birmingham\",\"country\":\"United Kingdom\"},{\"facility\":\"UCL Cancer Institute - University College London Hospitals NHS Foundation Trust\",\"city\":\"London\",\"country\":\"United Kingdom\"},{\"facility\":\"Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital\",\"city\":\"London\",\"country\":\"United Kingdom\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07763808\",\"briefTitle\":\"Surgical Treatment for Gingival Recessions After Orthodontic Treatment\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Aziz Aliyev Azerbaijan State Advanced Training Institute for Doctors\"}},\"conditionsModule\":{\"conditions\":[\"Gingival Recessions, Generalized\"]},\"designModule\":{\"phases\":[\"PHASE2\",\"PHASE3\"],\"enrollmentInfo\":{\"count\":75,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"PROCEDURE\",\"name\":\"Coronally advanced flap and a de-epithelialized soft tissue graft\"},{\"type\":\"PROCEDURE\",\"name\":\"Coronally advanced flap and a subepithelial connective tissue graft\"},{\"type\":\"PROCEDURE\",\"name\":\"Coronally advanced flap and Mucoderm soft tissue collagen graft\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Aziz Aliyev Azerbaijan State Advanced Training Institute for Doctors\",\"city\":\"Baku\",\"country\":\"Azerbaijan\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07815665\",\"briefTitle\":\"A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-10\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Summit Therapeutics\"}},\"conditionsModule\":{\"conditions\":[\"Metastatic Urothelial Carcinoma\",\"Metastatic Urothelial Carcinoma (UC)\"]},\"designModule\":{\"phases\":[\"PHASE2\",\"PHASE3\"],\"enrollmentInfo\":{\"count\":800,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Ivonescimab Dose 1\"},{\"type\":\"DRUG\",\"name\":\"enfortumab vedotin (EV)\"},{\"type\":\"DRUG\",\"name\":\"Pembrolizumab\"},{\"type\":\"DRUG\",\"name\":\"Ivonescimab Dose 2\"},{\"type\":\"DRUG\",\"name\":\"Ivonescimab RP3D\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Research Site\",\"city\":\"Phoenix\",\"country\":\"United States\"},{\"facility\":\"Research Site\",\"city\":\"Los Angeles\",\"country\":\"United States\"},{\"facility\":\"Research Site\",\"city\":\"Washington D.C.\",\"country\":\"United States\"},{\"facility\":\"Research Site\",\"city\":\"Jacksonville\",\"country\":\"United States\"},{\"facility\":\"Research Site\",\"city\":\"Rochester\",\"country\":\"United States\"},{\"facility\":\"Research Site\",\"city\":\"Nashville\",\"country\":\"United States\"},{\"facility\":\"Research Site\",\"city\":\"Spokane\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT06778564\",\"briefTitle\":\"Stratification and Treatment in Early Psychosis Study - ENHANCE\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"University of Oxford\"}},\"conditionsModule\":{\"conditions\":[\"Psychosis\",\"First Episode Psychosis\",\"Psychotic Disorders\",\"Psychotic Episode\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":250,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"CBD 100 mg/mL Oral Solution\"},{\"type\":\"OTHER\",\"name\":\"Placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"MedUni Vienna\",\"city\":\"Vienna\",\"country\":\"Austria\"},{\"facility\":\"University of Augsburg\",\"city\":\"Augsburg\",\"country\":\"Germany\"},{\"facility\":\"Charité Universitätsmedizin\",\"city\":\"Berlin\",\"country\":\"Germany\"},{\"facility\":\"University Hospital Cologne\",\"city\":\"Cologne\",\"country\":\"Germany\"},{\"facility\":\"Ludwig-Maximilian-University Munich\",\"city\":\"Munich\",\"country\":\"Germany\"},{\"facility\":\"National and Kapodistrian University of Athens\",\"city\":\"Athens\",\"country\":\"Greece\"},{\"facility\":\"Shalvata Mental Health Center\",\"city\":\"Hod HaSharon\",\"country\":\"Israel\"},{\"facility\":\"Geha Mental Health Center\",\"city\":\"Petah Tikva\",\"country\":\"Israel\"},{\"facility\":\"Sheba Medical Centre\",\"city\":\"Ramat Gan\",\"country\":\"Israel\"},{\"facility\":\"University of Campania 'Luigi Vanvitelli'\",\"city\":\"Naples\",\"country\":\"Italy\"},{\"facility\":\"Stichting Amsterdam UMC\",\"city\":\"Amsterdam\",\"country\":\"Netherlands\"},{\"facility\":\"Hospital General Universitario Gregorio Marañón\",\"city\":\"Madrid\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Virgen del Rocío\",\"city\":\"Seville\",\"country\":\"Spain\"},{\"facility\":\"Psychiatric University Hospital (PUK), Zurich\",\"city\":\"Zurich\",\"country\":\"Switzerland\"},{\"facility\":\"Cambridgeshire and Peterborough NHS Foundation Trust\",\"city\":\"Cambridge\",\"country\":\"United Kingdom\"},{\"facility\":\"West London NHS Trust\",\"city\":\"London\",\"country\":\"United Kingdom\"},{\"facility\":\"Oxford Health NHS Foundation Trust\",\"city\":\"Oxford\",\"country\":\"United Kingdom\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07570654\",\"briefTitle\":\"Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"COMPASS Pathways\"}},\"conditionsModule\":{\"conditions\":[\"PTSD - Post Traumatic Stress Disorder\",\"PTSD\",\"PTSD Symptoms\",\"PTSD, Post Traumatic Stress Disorder\"]},\"designModule\":{\"phases\":[\"PHASE2\",\"PHASE3\"],\"enrollmentInfo\":{\"count\":300,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"COMP360 psilocybin\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Florida\",\"city\":\"Orlando\",\"country\":\"United States\"},{\"facility\":\"NY\",\"city\":\"New York\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07623200\",\"briefTitle\":\"A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-08\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Incyte Corporation\"}},\"conditionsModule\":{\"conditions\":[\"Essential Thrombocythemia\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":426,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"INCA033989\"},{\"type\":\"DRUG\",\"name\":\"Best Available Treatment\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Banner Md Anderson Cancer Center\",\"city\":\"Gilbert\",\"country\":\"United States\"},{\"facility\":\"The University of Arizona Cancer Center\",\"city\":\"Tucson\",\"country\":\"United States\"},{\"facility\":\"City of Hope Medical Center\",\"city\":\"Duarte\",\"country\":\"United States\"},{\"facility\":\"Marin Cancer Care\",\"city\":\"Greenbrae\",\"country\":\"United States\"},{\"facility\":\"University of California, Los Angeles Medical Center\",\"city\":\"Los Angeles\",\"country\":\"United States\"},{\"facility\":\"Stanford Cancer Center\",\"city\":\"Palo Alto\",\"country\":\"United States\"},{\"facility\":\"Rocky Mountain Cancer Centers-Lone Tree\",\"city\":\"Lone Tree\",\"country\":\"United States\"},{\"facility\":\"Medstar Georgetown Medical Center, Inc\",\"city\":\"Washington D.C.\",\"country\":\"United States\"},{\"facility\":\"Florida Cancer Specialists & Research Institute\",\"city\":\"Fort Myers\",\"country\":\"United States\"},{\"facility\":\"University of Miami Sylvester Comprehensive Cancer Center\",\"city\":\"Miami\",\"country\":\"United States\"},{\"facility\":\"Cleveland Clinic\",\"city\":\"Weston\",\"country\":\"United States\"},{\"facility\":\"Winship Cancer Institute of Emory University\",\"city\":\"Atlanta\",\"country\":\"United States\"},{\"facility\":\"Robert H. Lurie Comprehensive Cancer Center of Northwestern University\",\"city\":\"Chicago\",\"country\":\"United States\"},{\"facility\":\"University of Chicago\",\"city\":\"Chicago\",\"country\":\"United States\"},{\"facility\":\"The University of Kansas Cancer Center\",\"city\":\"Westwood\",\"country\":\"United States\"},{\"facility\":\"Johns Hopkins Medicine-the Sidney Kimmel Comprehensive Cancer Center\",\"city\":\"Baltimore\",\"country\":\"United States\"},{\"facility\":\"Maryland Oncology Hematology, P.A.\",\"city\":\"Columbia\",\"country\":\"United States\"},{\"facility\":\"Massachusetts General Hospital\",\"city\":\"Boston\",\"country\":\"United States\"},{\"facility\":\"Beth Israel Deaconess Medical Center (Bidmc)\",\"city\":\"Boston\",\"country\":\"United States\"},{\"facility\":\"University of Massachusetts Medical School\",\"city\":\"Worcester\",\"country\":\"United States\"},{\"facility\":\"University of Michigan Rogel Cancer Center Adult Bone Marrow Transplant Clinic\",\"city\":\"Ann Arbor\",\"country\":\"United States\"},{\"facility\":\"Missouri Cancer Associates\",\"city\":\"Columbia\",\"country\":\"United States\"},{\"facility\":\"Washington University School of Medicine\",\"city\":\"St Louis\",\"country\":\"United States\"},{\"facility\":\"John Theurer Cancer Center, Hackensack University Medical Center\",\"city\":\"Hackensack\",\"country\":\"United States\"},{\"facility\":\"Rutgers Cancer Institute of New Jersey\",\"city\":\"New Brunswick\",\"country\":\"United States\"},{\"facility\":\"Icahn School of Medicine At Mount Sinai\",\"city\":\"New York\",\"country\":\"United States\"},{\"facility\":\"Memorial Sloan Kettering Cancer Center\",\"city\":\"New York\",\"country\":\"United States\"},{\"facility\":\"Weill Cornell Medical College - Newyork-Presbyterian Hospita\",\"city\":\"New York\",\"country\":\"United States\"},{\"facility\":\"Strong Memorial Hospital University of Rochester Medical Center\",\"city\":\"Rochester\",\"country\":\"United States\"},{\"facility\":\"Duke University Medical Center\",\"city\":\"Durham\",\"country\":\"United States\"},{\"facility\":\"Cleveland Clinic Taussig Cancer Ctr\",\"city\":\"Cleveland\",\"country\":\"United States\"},{\"facility\":\"Willamette Valley Cancer Institute and Research Center\",\"city\":\"Eugene\",\"country\":\"United States\"},{\"facility\":\"Oregon Health and Science University\",\"city\":\"Portland\",\"country\":\"United States\"},{\"facility\":\"Thomas Jefferson University Sidney Kimmel Medical College\",\"city\":\"Philadelphia\",\"country\":\"United States\"},{\"facility\":\"Vanderbilt University Medical Center\",\"city\":\"Nashville\",\"country\":\"United States\"},{\"facility\":\"Vanderbilt University Medical Center\",\"city\":\"Nashville\",\"country\":\"United States\"},{\"facility\":\"The University of Texas-Md Anderson Cancer Center\",\"city\":\"Houston\",\"country\":\"United States\"},{\"facility\":\"Ut Health Science Center At San Antonio\",\"city\":\"San Antonio\",\"country\":\"United States\"},{\"facility\":\"Texas Oncology-Tyler\",\"city\":\"Tyler\",\"country\":\"United States\"},{\"facility\":\"Huntsman Cancer Institute At University of Utah\",\"city\":\"Salt Lake City\",\"country\":\"United States\"},{\"facility\":\"University of Washington - Fred Hutch Cancer Center\",\"city\":\"Seattle\",\"country\":\"United States\"},{\"facility\":\"Blacktown Cancer & Haematology Centre-Blacktown Hospital\",\"city\":\"Blacktown\",\"country\":\"Australia\"},{\"facility\":\"Gosford Hospital (Gh) - Central Coast Cancer Centre\",\"city\":\"Gosford\",\"country\":\"Australia\"},{\"facility\":\"Liverpool Hospital - South Western Sydney Local Health District\",\"city\":\"Liverpool\",\"country\":\"Australia\"},{\"facility\":\"Sunshine Coast University Hospital\",\"city\":\"Birtinya\",\"country\":\"Australia\"},{\"facility\":\"Royal Brisbane and Women'S Hospital\",\"city\":\"Brisbane\",\"country\":\"Australia\"},{\"facility\":\"Peter Maccallum Cancer Centre\",\"city\":\"Melbourne\",\"country\":\"Australia\"},{\"facility\":\"Box Hill Hospital\",\"city\":\"Melbourne\",\"country\":\"Australia\"},{\"facility\":\"The Canberra Hospital\",\"city\":\"Garran\",\"country\":\"Australia\"},{\"facility\":\"Royal Perth Hospital\",\"city\":\"Perth\",\"country\":\"Australia\"},{\"facility\":\"Lkh - Medizinische Universitaet Graz\",\"city\":\"Graz\",\"country\":\"Austria\"},{\"facility\":\"Landeskrankenhaus (Lkh) Leoben - Standort Leoben\",\"city\":\"Leoben\",\"country\":\"Austria\"},{\"facility\":\"Ordensklinikum Linz Gmbh Elisabethinen\",\"city\":\"Linz\",\"country\":\"Austria\"},{\"facility\":\"Medizinische Universitaet Wien, Akh Wien\",\"city\":\"Vienna\",\"country\":\"Austria\"},{\"facility\":\"Klinikum Wels-Grieskirchen Gmbh\",\"city\":\"Wels\",\"country\":\"Austria\"},{\"facility\":\"Jules Bordet Lnstitute\",\"city\":\"Anderlecht\",\"country\":\"Belgium\"},{\"facility\":\"Centre Hospitalier Universitaire (Chu) Brugmann (Brugmann University Hospital (Uh)) - Victor Horta\",\"city\":\"Brussels\",\"country\":\"Belgium\"},{\"facility\":\"Universitair Ziekenhuis Leuven\",\"city\":\"Leuven\",\"country\":\"Belgium\"},{\"facility\":\"Centre Hospitalier Universitaire de Liege - Sart Tilman\",\"city\":\"Liège\",\"country\":\"Belgium\"},{\"facility\":\"Algemeen Ziekenhuis Deltaaretaie\",\"city\":\"Roeselare\",\"country\":\"Belgium\"},{\"facility\":\"Universite Catholique de Louvain (Ucl) - Cliniques Universitaires Saint-Luc\",\"city\":\"Woluwe-Saint-Lambert\",\"country\":\"Belgium\"},{\"facility\":\"St. Paul'S Hospital (Sph), Providence Health Care, University of British Columbia\",\"city\":\"Vancouver\",\"country\":\"Canada\"},{\"facility\":\"Margaret and Charles Juravinski Cancer Center\",\"city\":\"Hamilton\",\"country\":\"Canada\"},{\"facility\":\"Queens University, Kingston General Hospital (Kgh), Kingston Health Sciences Centre (Khsc)\",\"city\":\"Kingston\",\"country\":\"Canada\"},{\"facility\":\"University Health Network (Uhn) - Princess Margaret Cancer Centre\",\"city\":\"Toronto\",\"country\":\"Canada\"},{\"facility\":\"Sir Mortimer B. Davis - Jewish General Hospital\",\"city\":\"Montreal\",\"country\":\"Canada\"},{\"facility\":\"McGill University Health Centre - Glen Site, Centre For Innovative Medicine\",\"city\":\"Montreal\",\"country\":\"Canada\"},{\"facility\":\"Hotel-Dieu de Levis\",\"city\":\"Québec\",\"country\":\"Canada\"},{\"facility\":\"Fakultni Nemocnice Brno\",\"city\":\"Brno\",\"country\":\"Czechia\"},{\"facility\":\"Fakultni Nemocnice Ostrava\",\"city\":\"Ostrava-poruba\",\"country\":\"Czechia\"},{\"facility\":\"Faculty Hospital Kralovske Vinohrady\",\"city\":\"Prague\",\"country\":\"Czechia\"},{\"facility\":\"Vseobecna Fakultni Nemocnice V Praze\",\"city\":\"Prague\",\"country\":\"Czechia\"},{\"facility\":\"Ustav Hematologie A Krevni Transfuze (Uhkt)\",\"city\":\"Prague\",\"country\":\"Czechia\"},{\"facility\":\"Chu D'Amiens-Picardie - Hopital Sud\",\"city\":\"Amiens\",\"country\":\"France\"},{\"facility\":\"Institut Bergonie - Centre Regional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest\",\"city\":\"Bordeaux\",\"country\":\"France\"},{\"facility\":\"Chu de Brest Hopital de La Cavale Blanche Cic Hematologie\",\"city\":\"Brest\",\"country\":\"France\"},{\"facility\":\"Hospital Henri Mondor\",\"city\":\"Créteil\",\"country\":\"France\"},{\"facility\":\"Hopital Bicetre - Paris Sud (Ap-Hp)\",\"city\":\"Le Kremlin-Bicêtre\",\"country\":\"France\"},{\"facility\":\"Centre Hospitalier Universitaire de Nice,Hopital L Archet\",\"city\":\"Nice\",\"country\":\"France\"},{\"facility\":\"Hospital Saint-Louis - Aphp\",\"city\":\"Paris\",\"country\":\"France\"},{\"facility\":\"Centre Hospitalier Universitaire de Poitiers La Miletrie\",\"city\":\"Poitiers\",\"country\":\"France\"},{\"facility\":\"Institut Claudius Regaud Cancer Comprehensive Center - Iuct Oncopole\",\"city\":\"Toulouse\",\"country\":\"France\"},{\"facility\":\"Uniklinik Rwth Aachen Medizinische Klinik Iv\",\"city\":\"Aachen\",\"country\":\"Germany\"},{\"facility\":\"Charite - Universitaetsmedizin Berlin\",\"city\":\"Berlin\",\"country\":\"Germany\"},{\"facility\":\"Bag Onkologische Gemeinschaftspraxis Illmer, Jacobasch, Wolf, Freiberg-Richter Fae Fur Innere Medizi\",\"city\":\"Dresden\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsklinikum Freiburg\",\"city\":\"Freiburg im Breisgau\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsklinikum Halle\",\"city\":\"Halle\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsklinikum Hamburg-Eppendorf\",\"city\":\"Hamburg\",\"country\":\"Germany\"},{\"facility\":\"Medizinische Hochschule Hannover, Hannover Medical School\",\"city\":\"Hanover\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsklinikum Des Saarlandes Und Medizinische Fakultaet Der Universitaet Des Saarlandes\",\"city\":\"Homburg\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsklinikum Jena\",\"city\":\"Jena\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsklinikum Schleswig-Holstein (Uksh) - Campus Luebeck\",\"city\":\"Lübeck\",\"country\":\"Germany\"},{\"facility\":\"University Hospital Johannes Gutenberg - University of Mainz\",\"city\":\"Mainz\",\"country\":\"Germany\"},{\"facility\":\"Medizinische Fakultaet Mannheim Der Universitaet Heidelberg\",\"city\":\"Mannheim\",\"country\":\"Germany\"},{\"facility\":\"Johannes Wesling Klinikum Minden\",\"city\":\"Minden\",\"country\":\"Germany\"},{\"facility\":\"Semmelweis University-Internal Medicine and Haematology\",\"city\":\"Budapest\",\"country\":\"Hungary\"},{\"facility\":\"Debreceni Egyetem Klinikai Kozpont\",\"city\":\"Debrecen\",\"country\":\"Hungary\"},{\"facility\":\"University of Pecs\",\"city\":\"Pécs\",\"country\":\"Hungary\"},{\"facility\":\"Aou Policlinico Consorziale Bari - Uo Ematologia Con Trapianto\",\"city\":\"Bari\",\"country\":\"Italy\"},{\"facility\":\"Asst Papa Giovanni Xxiii (Azienda Ospedaliera Papa Giovanni Xxiii)\",\"city\":\"Bergamo\",\"country\":\"Italy\"},{\"facility\":\"Istituto Di Ematologia L. E A. Seragnoli-Azienda Ospedaliero Universitaria Policlinico S. Orsola Mal\",\"city\":\"Bologna\",\"country\":\"Italy\"},{\"facility\":\"Azienda Ospedaliero Universitaria Policlinico Gaspare Rodolico - San Marco\",\"city\":\"Catania\",\"country\":\"Italy\"},{\"facility\":\"Universita Degli Studi Di Firenze - Azienda Ospedaliero-Universitaria Careggi (Aouc)\",\"city\":\"Florence\",\"country\":\"Italy\"},{\"facility\":\"Irccs - Azienda Ospedaliera Universitaria - Ist San Martino\",\"city\":\"Genova\",\"country\":\"Italy\"},{\"facility\":\"Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori, Ematologia\",\"city\":\"Meldola\",\"country\":\"Italy\"},{\"facility\":\"Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico Di Milano\",\"city\":\"Milan\",\"country\":\"Italy\"},{\"facility\":\"Ao Maggiore Della Carita\",\"city\":\"Novara\",\"country\":\"Italy\"},{\"facility\":\"Universita Degli Studi Di Pavia-Fondazione Irccs Policlinico San Matteo\",\"city\":\"Pavia\",\"country\":\"Italy\"},{\"facility\":\"Ospedale S. Eugenio\",\"city\":\"Rome\",\"country\":\"Italy\"},{\"facility\":\"Universita Degli Studi Di Roma La Sapienza - Umberto I Policlinico Di Roma\",\"city\":\"Rome\",\"country\":\"Italy\"},{\"facility\":\"Universita Cattolica Del Sacro Cuore - Policlinico Universitario Agostino Gemelli\",\"city\":\"Rome\",\"country\":\"Italy\"},{\"facility\":\"Ao Ordine Mauriziano Di Torino\",\"city\":\"Torino\",\"country\":\"Italy\"},{\"facility\":\"Azienda Ospedaliero-Universitaria Santa Maria Della Misericordia\",\"city\":\"Udine\",\"country\":\"Italy\"},{\"facility\":\"Universita Degli Studi Di Verona\",\"city\":\"Verona\",\"country\":\"Italy\"},{\"facility\":\"Juntendo University Hospital\",\"city\":\"Bunkyō City\",\"country\":\"Japan\"},{\"facility\":\"Nippon Medical School Hospital\",\"city\":\"Bunkyō City\",\"country\":\"Japan\"},{\"facility\":\"University of Yamanashi Hospital\",\"city\":\"Chūō\",\"country\":\"Japan\"},{\"facility\":\"Kyushu University Hospital\",\"city\":\"Fukuoka\",\"country\":\"Japan\"},{\"facility\":\"Fukushima Medical University Hospital\",\"city\":\"Fukushima\",\"country\":\"Japan\"},{\"facility\":\"Kansai Medical University Hospital\",\"city\":\"Hirakata\",\"country\":\"Japan\"},{\"facility\":\"Kagoshima University Hospital\",\"city\":\"Kagoshima\",\"country\":\"Japan\"},{\"facility\":\"National Cancer Center Hospital East\",\"city\":\"Kashiwa-shi\",\"country\":\"Japan\"},{\"facility\":\"Kobe City Medical Center General Hospital\",\"city\":\"Kobe\",\"country\":\"Japan\"},{\"facility\":\"University of Miyazaki Hospital\",\"city\":\"Miyazaki\",\"country\":\"Japan\"},{\"facility\":\"Osaka Metropolitan University Hospital\",\"city\":\"Osaka\",\"country\":\"Japan\"},{\"facility\":\"Kindai University Hospital\",\"city\":\"Sakai\",\"country\":\"Japan\"},{\"facility\":\"Tokyo Medical University Hospital\",\"city\":\"Shinjuku-ku\",\"country\":\"Japan\"},{\"facility\":\"Ehime University Hospital\",\"city\":\"Tōon\",\"country\":\"Japan\"},{\"facility\":\"Mie University Graduate School of Medicine\",\"city\":\"Tsu\",\"country\":\"Japan\"},{\"facility\":\"Amsterdam Universitair Medisch Centrum, Locatie Amsterdam Medisch Centrum\",\"city\":\"Amsterdam\",\"country\":\"Netherlands\"},{\"facility\":\"University Medical Center Groningen\",\"city\":\"Groningen\",\"country\":\"Netherlands\"},{\"facility\":\"Radboud University Medical Center\",\"city\":\"Nijmegen\",\"country\":\"Netherlands\"},{\"facility\":\"Erasmus University Medical Center\",\"city\":\"Rotterdam\",\"country\":\"Netherlands\"},{\"facility\":\"Universitair Medisch Centrum Utrecht (Umc Utrecht)\",\"city\":\"Utrecht\",\"country\":\"Netherlands\"},{\"facility\":\"Haukeland University Hospital\",\"city\":\"Bergen\",\"country\":\"Norway\"},{\"facility\":\"Ostfold Hospital\",\"city\":\"Grålum\",\"country\":\"Norway\"},{\"facility\":\"Uniwersyteckie Centrum Kliniczne (Uck)\",\"city\":\"Gdansk\",\"country\":\"Poland\"},{\"facility\":\"Pratia Onkologia Katowice\",\"city\":\"Katowice\",\"country\":\"Poland\"},{\"facility\":\"Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie\",\"city\":\"Krakow\",\"country\":\"Poland\"},{\"facility\":\"Wojewodzkie Wielospecjalistyczne Centrum Onkologii I Traumatologii Im. M. Kopernika W Lodzi\",\"city\":\"Lodz\",\"country\":\"Poland\"},{\"facility\":\"Uniwersytecki Szpital Kliniczny Nr 1 W Lublinie\",\"city\":\"Lublin\",\"country\":\"Poland\"},{\"facility\":\"Instytut Hematologii I Transfuzjologii (Iht) (Institute of Haematology and Transfusion Medicine)\",\"city\":\"Warsaw\",\"country\":\"Poland\"},{\"facility\":\"Specjalistyczny Szpital Im. Dr Alfreda Sokolowskiego\",\"city\":\"Wałbrzych\",\"country\":\"Poland\"},{\"facility\":\"Pusan National University Hospital (Pnuh)\",\"city\":\"Busan\",\"country\":\"South Korea\"},{\"facility\":\"Seoul National University Bundang Hospital (Snubh)\",\"city\":\"Seongnam-si\",\"country\":\"South Korea\"},{\"facility\":\"Korea University Anam Hospital\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Seoul National University Hospital\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Severance Hospital Yonsei University Health System\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Asan Medical Center\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"The Catholic University of Korea Seoul St. Mary'S Hospital\",\"city\":\"Seoul\",\"country\":\"South Korea\"},{\"facility\":\"Hospital General Unviersitario de Alicante\",\"city\":\"Alicante\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Vall D'Hebron\",\"city\":\"Barcelona\",\"country\":\"Spain\"},{\"facility\":\"Hospital Clinic de Barcelona (Hospital Clinic I Provincial)\",\"city\":\"Barcelona\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario de Basurto\",\"city\":\"Bilbao\",\"country\":\"Spain\"},{\"facility\":\"Instituto Catalan de Oncologia - Hospital Duran I Reynals\",\"city\":\"L'Hospitalet de Llobregat\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario de Gran Canaria Doctor Negrin\",\"city\":\"Las Palmas de Gran Canaria\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Ramon Y Cajal\",\"city\":\"Madrid\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario 12 de Octubre\",\"city\":\"Madrid\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Puerta de Hierro de Majadahonda\",\"city\":\"Majadahonda\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Virgen de La Victoria\",\"city\":\"Málaga\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitari Son Espases\",\"city\":\"Palma\",\"country\":\"Spain\"},{\"facility\":\"Hospital Clinico Universitario de Salamanca\",\"city\":\"Salamanca\",\"country\":\"Spain\"},{\"facility\":\"Hospital Clinico Universitario de Santiago de Compostela\",\"city\":\"Santiago de Compostela\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Doctor Peset\",\"city\":\"Valencia\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Miguel Servet ( Hospital Infantil)\",\"city\":\"Zaragoza\",\"country\":\"Spain\"},{\"facility\":\"University Hospital Bern (Inselspital)\",\"city\":\"Bern\",\"country\":\"Switzerland\"},{\"facility\":\"Hoch Health Ostschweiz, Kantonsspital St. Gallen\",\"city\":\"Sankt Gallen\",\"country\":\"Switzerland\"},{\"facility\":\"Center of Oncology, Hematology and Transfusionmedicine\",\"city\":\"Tellstrasse\",\"country\":\"Switzerland\"},{\"facility\":\"Universitatsspital Zurich\",\"city\":\"Zurich\",\"country\":\"Switzerland\"},{\"facility\":\"Addenbrooke'S Hospital - Cambridge University Hospitals Nhs Foundation Trust\",\"city\":\"Cambridge\",\"country\":\"United Kingdom\"},{\"facility\":\"Western General Hospital - Lothian Health Board\",\"city\":\"Edinburgh\",\"country\":\"United Kingdom\"},{\"facility\":\"Northwick Park Hospital - London North West University Healthcare Nhs Trust\",\"city\":\"Harrow\",\"country\":\"United Kingdom\"},{\"facility\":\"St James'S University Hospital - Leeds Teaching Hospitals Nhs Trust\",\"city\":\"Leeds\",\"country\":\"United Kingdom\"},{\"facility\":\"Guy'S Hospital - Guy'S & St Thomas' Nhs Foundation Trust\",\"city\":\"London\",\"country\":\"United Kingdom\"},{\"facility\":\"Northern Centre For Cancer Care - the Newcastle Upon Tyne Hospitals Nhs Foundation Trust\",\"city\":\"Newcastle upon Tyne\",\"country\":\"United Kingdom\"},{\"facility\":\"Cancer and Haematology Centre-the Churchill Hospital-Oxford University Hospitals\",\"city\":\"Oxford\",\"country\":\"United Kingdom\"},{\"facility\":\"Royal Cornwall Hospital - Royal Cornwall Hospitals Nhs Trust\",\"city\":\"Penzance\",\"country\":\"United Kingdom\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07676162\",\"briefTitle\":\"A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal Cancer\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-08-28\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Suzhou Suncadia Biopharmaceuticals Co., Ltd.\"}},\"conditionsModule\":{\"conditions\":[\"Advanced Colorectal Cancer\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":300,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"SHR-A1811, Oxaliplatin, Levo-leucovorin, Fluorouracil and Bevacizumab\"},{\"type\":\"DRUG\",\"name\":\"Oxaliplatin, Levo-leucovorin, Fluorouracil and Bevacizumab\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Beijing cancer Hospital\",\"city\":\"Beijing\",\"country\":\"China\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07776210\",\"briefTitle\":\"Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD)\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Regenerative Ocular Immunobiologics LLC\"}},\"conditionsModule\":{\"conditions\":[\"oGVHD\",\"Ocular Graft Versus Host Disease\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":30,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"BIOLOGICAL\",\"name\":\"d-MAPPS™ Ophthalmic Solution\"},{\"type\":\"BIOLOGICAL\",\"name\":\"Matching vehicle control\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Beverly Hills Institute of Ophthalmology\",\"city\":\"Beverly Hills\",\"country\":\"United States\"},{\"facility\":\"Beverly Hills Optometry\",\"city\":\"Beverly Hills\",\"country\":\"United States\"},{\"facility\":\"Regenerative Ocular Immunobiologics, LLC.\",\"city\":\"Palm Harbor\",\"country\":\"United States\"},{\"facility\":\"Eyewell, LLC.\",\"city\":\"Boston\",\"country\":\"United States\"},{\"facility\":\"BostonSight\",\"city\":\"Boston\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07517133\",\"briefTitle\":\"A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Agios Pharmaceuticals, Inc.\"}},\"conditionsModule\":{\"conditions\":[\"Non-Transfusion-dependent Alpha-Thalassemia\",\"Non-Transfusion-dependent Beta-Thalassemia\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":45,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Mitapivat\"},{\"type\":\"DRUG\",\"name\":\"Placebo Matching Mitapivat\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Stanford Medicine\",\"city\":\"Palo Alto\",\"country\":\"United States\"},{\"facility\":\"Weill Cornell Medical College/ New York Presbyterian\",\"city\":\"New York\",\"country\":\"United States\"},{\"facility\":\"Children's Hospital of Philadelphia\",\"city\":\"Philadelphia\",\"country\":\"United States\"},{\"facility\":\"University of Texas Southwestern Medical Center\",\"city\":\"Dallas\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07408128\",\"briefTitle\":\"Partner4Exercise Study\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"McMaster University\"}},\"conditionsModule\":{\"conditions\":[\"Cancer\"]},\"designModule\":{\"phases\":[\"PHASE2\",\"PHASE3\"],\"enrollmentInfo\":{\"count\":183,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"BEHAVIORAL\",\"name\":\"Peer matching\"},{\"type\":\"BEHAVIORAL\",\"name\":\"Quailfied Exercise Professional (QEP) Support\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"McMaster University\",\"city\":\"Hamilton\",\"country\":\"Canada\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT06934655\",\"briefTitle\":\"Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youth\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Children's Hospital Los Angeles\"}},\"conditionsModule\":{\"conditions\":[\"Pediatric Obesity\",\"Metabolic and Bariatric Surgery\",\"Semaglutide\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":150,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Semaglutide 2.4 mg\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Children's Hospital Los Angeles\",\"city\":\"Los Angeles\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07212998\",\"briefTitle\":\"Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-08-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Jason Sperry\"}},\"conditionsModule\":{\"conditions\":[\"Burn Injury\",\"Thermal Burn\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":750,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"BIOLOGICAL\",\"name\":\"Plasma\"},{\"type\":\"BIOLOGICAL\",\"name\":\"Standard care\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"University of Pittsburgh\",\"city\":\"Pittsburgh\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07751133\",\"briefTitle\":\"Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-08-28\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"University College, London\"}},\"conditionsModule\":{\"conditions\":[\"Prostate Cancer\",\"mHSPC\",\"mCRPC\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":1500,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Abiraterone, Apalutamide, Enzalutamide or Darolutamide (ARPI therapy) (per standard of care) therapy\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"The Christie NHS Foundation Trust\",\"city\":\"Manchester\",\"country\":\"United Kingdom\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07772778\",\"briefTitle\":\"Evaluation of a Disability-Focused Sexual and Reproductive Health Curriculum for Health Students in Tanzania\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"University of Minnesota\"}},\"conditionsModule\":{\"conditions\":[\"Sexual and Reproductive Health\",\"Disability\",\"Health Knowledge, Attitudes, Practice\",\"Health Education\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":412,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"BEHAVIORAL\",\"name\":\"Disability-Focused Sexual and Reproductive Health Curriculum\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Muhimbili University of Health and Allied Sciences\",\"city\":\"Dar es Salaam\",\"country\":\"Tanzania\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07016321\",\"briefTitle\":\"Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Johns Hopkins University\"}},\"conditionsModule\":{\"conditions\":[\"Dengue\"]},\"designModule\":{\"phases\":[\"PHASE2\",\"PHASE3\"],\"enrollmentInfo\":{\"count\":600,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Emetine Hydrochloride 6mg\"},{\"type\":\"DRUG\",\"name\":\"Placebo\"},{\"type\":\"DRUG\",\"name\":\"Emetine Hydrochloride 12mg\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Johns Hopkins University, Division of Infectious Disease\",\"city\":\"Baltimore\",\"country\":\"United States\"},{\"facility\":\"Bharatpur Hospital\",\"city\":\"Bharatpur-10\",\"country\":\"Nepal\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07805954\",\"briefTitle\":\"Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-08-28\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Revolution Medicines, Inc.\"}},\"conditionsModule\":{\"conditions\":[\"Pancreatic Cancer\",\"Pancreatic Cancer Metastatic\",\"PDAC\",\"PDAC - Pancreatic Ductal Adenocarcinoma\",\"Pancreatic Ductal Adenocarcinoma (PDAC)\",\"Pancreatic Adenocarcinoma Metastatic\",\"Pancreatic Adenocarcinoma\",\"Pancreatic Adenosquamous Carcinoma\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":400,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"daraxonrasib\"},{\"type\":\"DRUG\",\"name\":\"gemcitabine\"},{\"type\":\"DRUG\",\"name\":\"nab-paclitaxel\"},{\"type\":\"DRUG\",\"name\":\"zoldonrasib\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Moffitt Cancer Center\",\"city\":\"Tampa\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07724366\",\"briefTitle\":\"A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.\"}},\"conditionsModule\":{\"conditions\":[\"Psoriasis\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":400,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"TQH3906 capsules\"},{\"type\":\"DRUG\",\"name\":\"Deucravacitinib tablets 6 mg\"},{\"type\":\"DRUG\",\"name\":\"TQH3906 Capsules placebo\"},{\"type\":\"DRUG\",\"name\":\"Deucravacitinib tablets placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Peking University Third Hospital\",\"city\":\"Beijing\",\"country\":\"China\"},{\"facility\":\"The First Affiliated Hospital of Chongqing Medical University 。\",\"city\":\"Chongqing\",\"country\":\"China\"},{\"facility\":\"Chongqing Traditional Chinese Medicine Hospital\",\"city\":\"Chongqing\",\"country\":\"China\"},{\"facility\":\"Dermatology Hospital of Southern Medical University\",\"city\":\"Guangzhou\",\"country\":\"China\"},{\"facility\":\"Guangdong Provincial People's Hospital\",\"city\":\"Guangzhou\",\"country\":\"China\"},{\"facility\":\"Shenzhen Second People's Hospital\",\"city\":\"Shenzhen\",\"country\":\"China\"},{\"facility\":\"The First Affiliated Hospital of Guangxi Medical University\",\"city\":\"Nanning\",\"country\":\"China\"},{\"facility\":\"Guizhou Provincial People's Hospital\",\"city\":\"Guiyang\",\"country\":\"China\"},{\"facility\":\"Hainan Fifth People's Hospital\",\"city\":\"Haikou\",\"country\":\"China\"},{\"facility\":\"Affiliated Hospital of Chengde Medical University\",\"city\":\"Chengde\",\"country\":\"China\"},{\"facility\":\"Shijiazhuang Traditional Chinese Medicine Hospital\",\"city\":\"Shijiazhuang\",\"country\":\"China\"},{\"facility\":\"Heilongjiang Provincial Hospital\",\"city\":\"Harbin\",\"country\":\"China\"},{\"facility\":\"The Second Affiliated Hospital of Henan University of science and technology\",\"city\":\"Luoyang\",\"country\":\"China\"},{\"facility\":\"Puyang Oilfield General Hospital\",\"city\":\"Puyang\",\"country\":\"China\"},{\"facility\":\"Zhengzhou Central Hospital\",\"city\":\"Zhengzhou\",\"country\":\"China\"},{\"facility\":\"The First Peopel's Hospital of Zhengzhou\",\"city\":\"Zhengzhou\",\"country\":\"China\"},{\"facility\":\"Jingzhou Central Hospital\",\"city\":\"Jingzhou\",\"country\":\"China\"},{\"facility\":\"Xiangya Hospital of Central South University\",\"city\":\"Changsha\",\"country\":\"China\"},{\"facility\":\"The Third Xiangya Hospital of Central South University\",\"city\":\"Changsha\",\"country\":\"China\"},{\"facility\":\"Affiliated Hospital of Inner Mongolia Medical University\",\"city\":\"Hohhot\",\"country\":\"China\"},{\"facility\":\"The First People's Hospital of Lianyungang\",\"city\":\"Lianyungang\",\"country\":\"China\"},{\"facility\":\"Chinese Academy of Medical Sciences Hospital for Skin Diseases\",\"city\":\"Nanjing\",\"country\":\"China\"},{\"facility\":\"Nantong Cancer Hospital\",\"city\":\"Nantong\",\"country\":\"China\"},{\"facility\":\"Suzhou Municipal Hospital\",\"city\":\"Suzhou\",\"country\":\"China\"},{\"facility\":\"Affiliated Hospital of Jiangsu University\",\"city\":\"Zhenjiang\",\"country\":\"China\"},{\"facility\":\"The Second Hospital of Jilin University\",\"city\":\"Changchun\",\"country\":\"China\"},{\"facility\":\"Zhongyi Northeast International Hospital Co., Ltd.\",\"city\":\"Shengyang\",\"country\":\"China\"},{\"facility\":\"The First Affiliated Hospital of China Medical University\",\"city\":\"Shenyang\",\"country\":\"China\"},{\"facility\":\"Shenyang Seventh People's Hospital (Shenyang Hospital of Integrated Traditional Chinese and Western Medicine, Shenyang Dermatology Hospital)\",\"city\":\"Shenyang\",\"country\":\"China\"},{\"facility\":\"Central Hospital Affiliated to Shenyang Medical College\",\"city\":\"Shenyang\",\"country\":\"China\"},{\"facility\":\"The First People's Hospital of Xining\",\"city\":\"Xining\",\"country\":\"China\"},{\"facility\":\"The Second Affiliated Hospital of Xi'an Jiaotong University\",\"city\":\"Xi'an\",\"country\":\"China\"},{\"facility\":\"Qilu Hospital Dezhou Branch of Shandong University (Dezhou People's Hospital)\",\"city\":\"Dezhou\",\"country\":\"China\"},{\"facility\":\"Jining No.1 People'S Hospital\",\"city\":\"Jining\",\"country\":\"China\"},{\"facility\":\"Qingdao Municipal Hospital\",\"city\":\"Qingdao\",\"country\":\"China\"},{\"facility\":\"Huashan Hospital, Fudan University\",\"city\":\"Shanghai\",\"country\":\"China\"},{\"facility\":\"The Second People's Hospital of ChangZhi\",\"city\":\"Changzhi\",\"country\":\"China\"},{\"facility\":\"Suining Central Hospital\",\"city\":\"Suining\",\"country\":\"China\"},{\"facility\":\"Gerneral Hospital of Ningxia Medical Univercity\",\"city\":\"Yinchuan\",\"country\":\"China\"},{\"facility\":\"Tianjin First Central Hospital\",\"city\":\"Tianjin\",\"country\":\"China\"},{\"facility\":\"Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital\",\"city\":\"Tianjin\",\"country\":\"China\"},{\"facility\":\"The First Affiliated Hospital of Kunming Medical University\",\"city\":\"Kunming\",\"country\":\"China\"},{\"facility\":\"Jiaxing First Hospital\",\"city\":\"Jiaxing\",\"country\":\"China\"},{\"facility\":\"Jinhua Municipal Central Hospital\",\"city\":\"Jinhua\",\"country\":\"China\"},{\"facility\":\"The First Affiliated Hospital of Ningbo University\",\"city\":\"Ningbo\",\"country\":\"China\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07506863\",\"briefTitle\":\"A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Agios Pharmaceuticals, Inc.\"}},\"conditionsModule\":{\"conditions\":[\"Transfusion-dependent Alpha-Thalassemia\",\"Transfusion-dependent Beta-Thalassemia\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":54,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Mitapivat Matched Placebo\"},{\"type\":\"DRUG\",\"name\":\"Mitapivat\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Weill Cornell Medical College/ New York Presbyterian\",\"city\":\"New York\",\"country\":\"United States\"},{\"facility\":\"Children's Hospital of Philadelphia\",\"city\":\"Philadelphia\",\"country\":\"United States\"},{\"facility\":\"University of Texas Southwestern Medical Center\",\"city\":\"Dallas\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07648264\",\"briefTitle\":\"Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-11\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"CSL Behring\"}},\"conditionsModule\":{\"conditions\":[\"Secondary Immune Deficiency\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":63,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"BIOLOGICAL\",\"name\":\"IgPro20\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"UC Irvine\",\"city\":\"Orange\",\"country\":\"United States\"},{\"facility\":\"CBCI, Colorado Blood Cancer Institute\",\"city\":\"Denver\",\"country\":\"United States\"},{\"facility\":\"SSAK Partners\",\"city\":\"Coral Springs\",\"country\":\"United States\"},{\"facility\":\"Mayo Clinic - Jacksonville\",\"city\":\"Jacksonville\",\"country\":\"United States\"},{\"facility\":\"Indiana University Health Arnett, Inc.\",\"city\":\"Lafayette\",\"country\":\"United States\"},{\"facility\":\"Johns Hopkins Asthma & Allergy Center\",\"city\":\"Baltimore\",\"country\":\"United States\"},{\"facility\":\"American Oncology Partners, PA dba The Center for Cancer and Blood Disorders\",\"city\":\"Bethesda\",\"country\":\"United States\"},{\"facility\":\"Hackensack Meridian Health\",\"city\":\"Hackensack\",\"country\":\"United States\"},{\"facility\":\"Carol G Simon Cancer Center\",\"city\":\"Morristown\",\"country\":\"United States\"},{\"facility\":\"David H. Koch Center for Cancer Care\",\"city\":\"New York\",\"country\":\"United States\"},{\"facility\":\"Montefiore Medical Center PRIME\",\"city\":\"The Bronx\",\"country\":\"United States\"},{\"facility\":\"Duke University\",\"city\":\"Durham\",\"country\":\"United States\"},{\"facility\":\"University of Cincinnati Medical Center\",\"city\":\"Cincinnati\",\"country\":\"United States\"},{\"facility\":\"Penn State Hershey Medical Center\",\"city\":\"Hershey\",\"country\":\"United States\"},{\"facility\":\"The University of Texas MD Anderson Cancer Center\",\"city\":\"Houston\",\"country\":\"United States\"},{\"facility\":\"Fred Hutchinson Cancer Research Center\",\"city\":\"Seattle\",\"country\":\"United States\"},{\"facility\":\"Medical College of Wisconsin\",\"city\":\"Milwaukee\",\"country\":\"United States\"},{\"facility\":\"Universitair ziekenhuis Antwerpen UZA\",\"city\":\"Edegem\",\"country\":\"Belgium\"},{\"facility\":\"AZ Delta\",\"city\":\"Roeselare\",\"country\":\"Belgium\"},{\"facility\":\"UZ Gent\",\"city\":\"Ghent\",\"country\":\"Belgium\"},{\"facility\":\"CHU de Liège\",\"city\":\"Liège\",\"country\":\"Belgium\"},{\"facility\":\"Horizon Health Network\",\"city\":\"Fredericton\",\"country\":\"Canada\"},{\"facility\":\"McGill University Health Research Institute\",\"city\":\"Montreal\",\"country\":\"Canada\"},{\"facility\":\"FH Ostrova\",\"city\":\"Ostrova\",\"country\":\"Czechia\"},{\"facility\":\"FH Hradec Kralove\",\"city\":\"Hradec Králové\",\"country\":\"Czechia\"},{\"facility\":\"Fakultni nemocnice Kralovske Vinohrady\",\"city\":\"Prague\",\"country\":\"Czechia\"},{\"facility\":\"UHKT Praha\",\"city\":\"Prague\",\"country\":\"Czechia\"},{\"facility\":\"Department of Medicine, Vejle Hospital\",\"city\":\"Vejle\",\"country\":\"Denmark\"},{\"facility\":\"Rigshospitalet\",\"city\":\"Copenhagen\",\"country\":\"Denmark\"},{\"facility\":\"Zealand University Hospital\",\"city\":\"Roskilde\",\"country\":\"Denmark\"},{\"facility\":\"CHU Rennes - Hopital Pontchaillou\",\"city\":\"Rennes\",\"country\":\"France\"},{\"facility\":\"CHU de Nantes-Hotel Dieu\",\"city\":\"Nantes\",\"country\":\"France\"},{\"facility\":\"CHU Angers - Hôpital Hôtel Dieu\",\"city\":\"Angers\",\"country\":\"France\"},{\"facility\":\"Centre Hospitalier Départemental Les Oudairies\",\"city\":\"La Roche-sur-Yon\",\"country\":\"France\"},{\"facility\":\"Centre Henri Becquerel\",\"city\":\"Rouen\",\"country\":\"France\"},{\"facility\":\"Universitaetsklinikum Giessen und Marburg GmbH Standort Giessen\",\"city\":\"Giessen\",\"country\":\"Germany\"},{\"facility\":\"Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz\",\"city\":\"Mainz\",\"country\":\"Germany\"},{\"facility\":\"Fondazione Policlinico Universitario A. gemelli, IRCCS\",\"city\":\"Rome\",\"country\":\"Italy\"},{\"facility\":\"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Montichiari)\",\"city\":\"Brescia\",\"country\":\"Italy\"},{\"facility\":\"Ospedale di Circolo Fondazione Macchi\",\"city\":\"Varese\",\"country\":\"Italy\"},{\"facility\":\"Fondazione del Piemonte per l'Oncologia IRCCS Candiolo\",\"city\":\"Candiolo\",\"country\":\"Italy\"},{\"facility\":\"Azienda Ospedaliero Universitaria Policlinico \\\"Gaspare Rodolico - San Marco\\\" (Presidio G. Rodolico)\",\"city\":\"Catania\",\"country\":\"Italy\"},{\"facility\":\"Azienda Ospedaliera Universitaria Careggi\",\"city\":\"Florence\",\"country\":\"Italy\"},{\"facility\":\"Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico\",\"city\":\"Milan\",\"country\":\"Italy\"},{\"facility\":\"Ospedale San Raffaele\",\"city\":\"Milan\",\"country\":\"Italy\"},{\"facility\":\"MICS Centrum Medyczne Torun\",\"city\":\"Torun\",\"country\":\"Poland\"},{\"facility\":\"Pratia MCM Krakow\",\"city\":\"Krakow\",\"country\":\"Poland\"},{\"facility\":\"Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy\",\"city\":\"Gliwice\",\"country\":\"Poland\"},{\"facility\":\"Pratia Onkologia Katowice\",\"city\":\"Katowice\",\"country\":\"Poland\"},{\"facility\":\"Aidport sp z o.o.\",\"city\":\"Skorzewo (Poznan)\",\"country\":\"Poland\"},{\"facility\":\"Hospital Universitario del Vinalopó\",\"city\":\"Elche\",\"country\":\"Spain\"},{\"facility\":\"Hospital Clinic de Barcelona\",\"city\":\"Barcelona\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitari Germans Trias i Pujol\",\"city\":\"Badalona\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Marques de Valdecilla\",\"city\":\"Santander\",\"country\":\"Spain\"},{\"facility\":\"Vall d'Hebron Institut d'Oncologia\",\"city\":\"Barcelona\",\"country\":\"Spain\"},{\"facility\":\"Pratia ES HLA Hospital Universitario Moncloa\",\"city\":\"Madrid\",\"country\":\"Spain\"},{\"facility\":\"Hospital Universitario Fundacion Jimenez Diaz\",\"city\":\"Madrid\",\"country\":\"Spain\"},{\"facility\":\"Hammersmith Hospital\",\"city\":\"London\",\"country\":\"United Kingdom\"},{\"facility\":\"Leicester Royal Infirmary\",\"city\":\"Leicester\",\"country\":\"United Kingdom\"},{\"facility\":\"St Bartholomew's Hospital\",\"city\":\"London\",\"country\":\"United Kingdom\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07796789\",\"briefTitle\":\"Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-08-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Sun Yat-sen University\"}},\"conditionsModule\":{\"conditions\":[\"Nasopharyngeal Cancinoma (NPC)\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":204,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Nanocrystalline Megestrol Acetate Oral Suspension\"},{\"type\":\"DRUG\",\"name\":\"Placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Sun Yat-sen University Cancer Cente\",\"city\":\"Guangzhou\",\"country\":\"China\"},{\"facility\":\"Hunan Cancer Hospital\",\"city\":\"Changsha\",\"country\":\"China\"},{\"facility\":\"Fujian Cancer Hospital\",\"city\":\"Fuzhou\",\"country\":\"China\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07540364\",\"briefTitle\":\"A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Suven Life Sciences Limited\"}},\"conditionsModule\":{\"conditions\":[\"Narcolepsy\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":240,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Samelisant\"},{\"type\":\"DRUG\",\"name\":\"Placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Bogan Sleep Consultants\",\"city\":\"Columbia\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07151417\",\"briefTitle\":\"Use of Corticosteroid in Intraopertive Injections in Total Knee Replacement Surgery.\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Walter Reed National Military Medical Center\"}},\"conditionsModule\":{\"conditions\":[\"Knee Osteoarthritis\",\"Musculoskeletal Disease\",\"Surgery\"]},\"designModule\":{\"phases\":[\"PHASE2\",\"PHASE3\"],\"enrollmentInfo\":{\"count\":240,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"PAI\"},{\"type\":\"DRUG\",\"name\":\"PAI + steroid\"},{\"type\":\"DRUG\",\"name\":\"PAI + zilretta\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Walter Reed National Military Medical Center\",\"city\":\"Bethesda\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07623135\",\"briefTitle\":\"Lumateperone for Late-Life Depression\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Eric Lenze\"}},\"conditionsModule\":{\"conditions\":[\"Treatment Resistant Depression (TRD)\",\"Late Life Depression (LLD)\",\"Depression / Major Depressive Disorder\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":100,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Lumateperone\"},{\"type\":\"DRUG\",\"name\":\"Placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"University of Arizona\",\"city\":\"Tucson\",\"country\":\"United States\"},{\"facility\":\"Washington University School of Medicine\",\"city\":\"St Louis\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04563520\",\"briefTitle\":\"SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Emory University\"}},\"conditionsModule\":{\"conditions\":[\"Hemophilia A\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":5,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Emicizumab\"},{\"type\":\"DRUG\",\"name\":\"FEIBA\"},{\"type\":\"DRUG\",\"name\":\"rFVIIa\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Children's Healthcare of Atlanta\",\"city\":\"Atlanta\",\"country\":\"United States\"},{\"facility\":\"Emory University Hospital\",\"city\":\"Atlanta\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07444450\",\"briefTitle\":\"A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec\"},\"statusModule\":{\"overallStatus\":\"RECRUITING\",\"startDateStruct\":{\"date\":\"2026-09-04\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Biogen\"}},\"conditionsModule\":{\"conditions\":[\"Muscular Atrophy, Spinal\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":42,\"type\":\"ESTIMATED\"}},\"armsInterventionsModule\":{\"interventions\":[{\"type\":\"DRUG\",\"name\":\"Salanersen\"},{\"type\":\"PROCEDURE\",\"name\":\"Sham Procedure\"}]},\"contactsLocationsModule\":{\"locations\":[{\"facility\":\"Neurology Rare Disease Center\",\"city\":\"Flower Mound\",\"country\":\"United States\"}]}}}\n],\"nextPageToken\":\"ZVt07cGHkvI2wRk2CJf6_LLtz5GYPNRrd7KrgP4YmT6Suvo7IQ\"}",
    "content_length": 73711,
    "content_type": "application/json",
    "description": "",
    "status_code": 200,
    "success": true,
    "title": "",
    "url": "https://clinicaltrials.gov/api/v2/studies"
  },
  "error": "",
  "elapsed": 0.217400351
}

{
  "tool_name": "web_fetch",
  "tool_input": {
    "brief": "total count of matching studies",
    "url": "https://clinicaltrials.gov/api/v2/studies?filter.advanced=%5BREDACTED%5D&query.term=%5BREDACTED%5D&pageSize=%5BREDACTED%5D&countTotal=%5BREDACTED%5D&fields=%5BREDACTED%5D"
  },
  "dispatch_id": "toolu_01F1Jh3gnVfUiTq1Sj1W1PvA",
  "parent_dispatch_id": "",
  "handle": "",
  "panel_kind": "web_fetch"
}

{
  "tool_name": "web_fetch",
  "dispatch_id": "toolu_01F1Jh3gnVfUiTq1Sj1W1PvA",
  "status": "running",
  "result": null,
  "error": "",
  "elapsed": null,
  "fields": {
    "progress": {
      "message": "total count of matching studies",
      "metadata": {
        "browser_chain": false,
        "url": "https://clinicaltrials.gov/api/v2/studies?filter.advanced=%5BREDACTED%5D&query.term=%5BREDACTED%5D&pageSize=%5BREDACTED%5D&countTotal=%5BREDACTED%5D&fields=%5BREDACTED%5D"
      }
    },
    "status": "running",
    "updatedAt": 1789169502155
  }
}

{
  "tool_name": "web_fetch",
  "dispatch_id": "toolu_01F1Jh3gnVfUiTq1Sj1W1PvA",
  "status": "completed",
  "result": {
    "content": "{\"totalCount\":44,\"studies\":[\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07738172\"}}}\n],\"nextPageToken\":\"ZVt07cGHkvI2wRk2CJf6_LLtz5GYPNRrd7KrgP4flDuXsPE\"}",
    "content_length": 166,
    "content_type": "application/json",
    "description": "",
    "status_code": 200,
    "success": true,
    "title": "",
    "url": "https://clinicaltrials.gov/api/v2/studies"
  },
  "error": "",
  "elapsed": 0.078630303
}

{
  "tool_name": "web_fetch",
  "tool_input": {
    "brief": "page 2 of results",
    "url": "https://clinicaltrials.gov/api/v2/studies?filter.advanced=%5BREDACTED%5D&query.term=%5BREDACTED%5D&pageSize=%5BREDACTED%5D&pageToken=%5BREDACTED%5D&fields=%5BREDACTED%5D"
  },
  "dispatch_id": "toolu_01EqUzmA8ik8oCSnniefy2qx",
  "parent_dispatch_id": "",
  "handle": "",
  "panel_kind": "web_fetch"
}

{
  "tool_name": "web_fetch",
  "dispatch_id": "toolu_01EqUzmA8ik8oCSnniefy2qx",
  "status": "running",
  "result": null,
  "error": "",
  "elapsed": null,
  "fields": {
    "progress": {
      "message": "page 2 of results",
      "metadata": {
        "browser_chain": false,
        "url": "https://clinicaltrials.gov/api/v2/studies?filter.advanced=%5BREDACTED%5D&query.term=%5BREDACTED%5D&pageSize=%5BREDACTED%5D&pageToken=%5BREDACTED%5D&fields=%5BREDACTED%5D"
      }
    },
    "status": "running",
    "updatedAt": 1789169508309
  }
}

{
  "tool_name": "web_fetch",
  "dispatch_id": "toolu_01EqUzmA8ik8oCSnniefy2qx",
  "status": "completed",
  "result": {
    "content": "{\"studies\":[\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07225972\",\"briefTitle\":\"Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"New York Medical College\"}},\"conditionsModule\":{\"conditions\":[\"CMV\",\"AdV Infection\",\"AdV Reactivation\",\"Adenovirus\",\"Cytomegalovirus Infections\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":138}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"Standard of Care Antiviral medications\"},{\"name\":\"Viral CTLs\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Valhalla\",\"country\":\"United States\"},{\"city\":\"Milwaukee\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07807865\",\"briefTitle\":\"A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-09-03\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Intra-Cellular Therapies, Inc.\"}},\"conditionsModule\":{\"conditions\":[\"Generalized Anxiety Disorder\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":900}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"ITI-1284\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Los Angeles\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07768345\",\"briefTitle\":\"A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-08-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Pfizer\"}},\"conditionsModule\":{\"conditions\":[\"Respiratory Syncytial Virus (RSV)\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":440}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"RSVpreF Vaccine\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Los Angeles\",\"country\":\"United States\"},{\"city\":\"Los Angeles\",\"country\":\"United States\"},{\"city\":\"Los Angeles\",\"country\":\"United States\"},{\"city\":\"Decatur\",\"country\":\"United States\"},{\"city\":\"Rochester\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07587242\",\"briefTitle\":\"A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-09-01\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Avidity Biosciences, Inc.\"}},\"conditionsModule\":{\"conditions\":[\"Muscular Dystrophies\",\"Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy)\",\"Muscular Disorders, Atrophic\",\"Muscular Disease\",\"Musculoskeletal Diseases\",\"Neuromuscular Diseases (NMD)\",\"Nervous System Diseases\",\"Genetic Diseases\",\"X-Linked\",\"Hereditary\",\"Neonatal Disease\",\"Duchene Muscular Dystrophy\",\"Congenital\",\"DMD\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":70}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"AOC 1044\"},{\"name\":\"Placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Leuven\",\"country\":\"Belgium\"},{\"city\":\"Liège\",\"country\":\"Belgium\"},{\"city\":\"Paris\",\"country\":\"France\"},{\"city\":\"Essen\",\"country\":\"Germany\"},{\"city\":\"Heidelberg\",\"country\":\"Germany\"},{\"city\":\"München\",\"country\":\"Germany\"},{\"city\":\"Milan\",\"country\":\"Italy\"},{\"city\":\"Roma\",\"country\":\"Italy\"},{\"city\":\"Barcelona\",\"country\":\"Spain\"},{\"city\":\"Madrid\",\"country\":\"Spain\"},{\"city\":\"Seville\",\"country\":\"Spain\"},{\"city\":\"Newcastle\",\"country\":\"United Kingdom\"},{\"city\":\"Oxford\",\"country\":\"United Kingdom\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07778316\",\"briefTitle\":\"Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-08-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Amgen\"}},\"conditionsModule\":{\"conditions\":[\"Small Cell Lung Cancer\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":400}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"Tarlatamab\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Grand Rapids\",\"country\":\"United States\"},{\"city\":\"Shanghai\",\"country\":\"China\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07285239\",\"briefTitle\":\"Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"PrECOG, LLC.\"}},\"conditionsModule\":{\"conditions\":[\"Multiple Myeloma\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":500}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"Arm A: Belantamab Mafodotin\"},{\"name\":\"Arm B: Daratumumab Hyaluronidase\"},{\"name\":\"Bortezomib\"},{\"name\":\"Lenalidomide\"},{\"name\":\"Dexamethasone\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"La Crosse\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07493304\",\"briefTitle\":\"Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-08-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Regeneron Pharmaceuticals\"}},\"conditionsModule\":{\"conditions\":[\"Venous Thromboembolism (VTE)\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":1600}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"REGN7508\"},{\"name\":\"Apixaban\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Hialeah\",\"country\":\"United States\"},{\"city\":\"New York\",\"country\":\"United States\"},{\"city\":\"El Paso\",\"country\":\"United States\"},{\"city\":\"Yongin-si\",\"country\":\"South Korea\"},{\"city\":\"Pusan\",\"country\":\"South Korea\"},{\"city\":\"Seoul\",\"country\":\"South Korea\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07809256\",\"briefTitle\":\"A Prospective, Single-center, Non-randomized, Interventional Study on the Effectiveness and Safety of Combined Immunotargeted Therapy in Patients With Metastatic Non-small Cell Cancer With a RET Gene Translocation\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"EuroCityClinic LLC\"}},\"conditionsModule\":{\"conditions\":[\"NSCLC (Non-small Cell Lung Cancer)R\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":15}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"lenvatinib pembrolizumab\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Saint Petersburg\",\"country\":\"Russia\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07679360\",\"briefTitle\":\"A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-09-02\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Suzhou Suncadia Biopharmaceuticals Co., Ltd.\"}},\"conditionsModule\":{\"conditions\":[\"Triple Negative Breast Cancer\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":1000}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"Trastuzumab Rezetecan for Injection\"},{\"name\":\"Adebrelimab Injection\"},{\"name\":\"Capecitabine tablets\"},{\"name\":\"Pembrolizumab injection\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Beijing\",\"country\":\"China\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07743983\",\"briefTitle\":\"A Study of BGM0504 in Early T2DM With Obesity\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-08-30\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"BrightGene Bio-Medical Technology Co., Ltd.\"}},\"conditionsModule\":{\"conditions\":[\"Type 2 Diabetes (T2DM)\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":372}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"BGM0504\"},{\"name\":\"semaglutide\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Nanjing\",\"country\":\"China\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07594119\",\"briefTitle\":\"Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-09\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Rapport Therapeutics Inc.\"}},\"conditionsModule\":{\"conditions\":[\"Focal Seizure\",\"Epilepsy\",\"Focal Epilepsy\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":312}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"RAP-219\"},{\"name\":\"RAP-219\"},{\"name\":\"Placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Huntsville\",\"country\":\"United States\"},{\"city\":\"Bentonville\",\"country\":\"United States\"},{\"city\":\"Colorado Springs\",\"country\":\"United States\"},{\"city\":\"Maitland\",\"country\":\"United States\"},{\"city\":\"Miami\",\"country\":\"United States\"},{\"city\":\"Chicago\",\"country\":\"United States\"},{\"city\":\"New York\",\"country\":\"United States\"},{\"city\":\"Raleigh\",\"country\":\"United States\"},{\"city\":\"Nashville\",\"country\":\"United States\"},{\"city\":\"Houston\",\"country\":\"United States\"},{\"city\":\"Houston\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07816185\",\"briefTitle\":\"A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-08-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Pulmovant, Inc.\"}},\"conditionsModule\":{\"conditions\":[\"Pulmonary Hypertension\",\"Interstitial Lung Disease\",\"Vascular Diseases\",\"Cardiovascular Diseases\",\"Fibrosis\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":376}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"Mosliciguat\"},{\"name\":\"Placebo\"},{\"name\":\"Dry Powder Inhaler\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Kissimmee\",\"country\":\"United States\"},{\"city\":\"Louisville\",\"country\":\"United States\"},{\"city\":\"Bend\",\"country\":\"United States\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT07743580\",\"briefTitle\":\"A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-08-31\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"Shionogi\"}},\"conditionsModule\":{\"conditions\":[\"SARS-CoV-2\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":2000}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"Secutrelvir\"},{\"name\":\"Placebo\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Coral Gables\",\"country\":\"United States\"},{\"city\":\"Miami\",\"country\":\"United States\"},{\"city\":\"Miami\",\"country\":\"United States\"},{\"city\":\"Miami\",\"country\":\"United States\"},{\"city\":\"St. Petersburg\",\"country\":\"United States\"},{\"city\":\"Tampa\",\"country\":\"United States\"},{\"city\":\"Tampa\",\"country\":\"United States\"},{\"city\":\"Cincinnati\",\"country\":\"United States\"},{\"city\":\"Sevlievo\",\"country\":\"Bulgaria\"},{\"city\":\"Sofia\",\"country\":\"Bulgaria\"},{\"city\":\"Haskovo\",\"country\":\"Bulgaria\"},{\"city\":\"Lovech\",\"country\":\"Bulgaria\"},{\"city\":\"Pleven\",\"country\":\"Bulgaria\"},{\"city\":\"Kasugai-Shi\",\"country\":\"Japan\"},{\"city\":\"Chiba\",\"country\":\"Japan\"},{\"city\":\"Nihommatsu\",\"country\":\"Japan\"},{\"city\":\"Maebashi\",\"country\":\"Japan\"},{\"city\":\"Takasaki-shi\",\"country\":\"Japan\"},{\"city\":\"Akashi-Shi\",\"country\":\"Japan\"},{\"city\":\"Himeji-shi\",\"country\":\"Japan\"},{\"city\":\"Tsuchiura-Shi\",\"country\":\"Japan\"},{\"city\":\"Kawasaki-shi\",\"country\":\"Japan\"},{\"city\":\"Kawasaki-shi\",\"country\":\"Japan\"},{\"city\":\"Sendai\",\"country\":\"Japan\"},{\"city\":\"Sendai\",\"country\":\"Japan\"},{\"city\":\"Kawaguchi-shi\",\"country\":\"Japan\"},{\"city\":\"Chuo-Ku\",\"country\":\"Japan\"},{\"city\":\"Edogawa-ku\",\"country\":\"Japan\"},{\"city\":\"Koto-ku\",\"country\":\"Japan\"},{\"city\":\"Musashino\",\"country\":\"Japan\"},{\"city\":\"Shibuya-Ku\",\"country\":\"Japan\"},{\"city\":\"Shinjuku-Ku\",\"country\":\"Japan\"},{\"city\":\"Toshima-ku\",\"country\":\"Japan\"},{\"city\":\"Fukuoka\",\"country\":\"Japan\"}]}}},\n{\"protocolSection\":{\"identificationModule\":{\"nctId\":\"NCT04990128\",\"briefTitle\":\"Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis\"},\"statusModule\":{\"startDateStruct\":{\"date\":\"2026-08-28\"}},\"sponsorCollaboratorsModule\":{\"leadSponsor\":{\"name\":\"The Cleveland Clinic\"}},\"conditionsModule\":{\"conditions\":[\"Hip Osteoarthritis\"]},\"designModule\":{\"phases\":[\"PHASE3\"],\"enrollmentInfo\":{\"count\":100}},\"armsInterventionsModule\":{\"interventions\":[{\"name\":\"Aspire Needle + Emcyte PureBMC\"},{\"name\":\"Triamcinolone\"}]},\"contactsLocationsModule\":{\"locations\":[{\"city\":\"Weston\",\"country\":\"United States\"}]}}}\n]}",
    "content_length": 12678,
    "content_type": "application/json",
    "description": "",
    "status_code": 200,
    "success": true,
    "title": "",
    "url": "https://clinicaltrials.gov/api/v2/studies"
  },
  "error": "",
  "elapsed": 0.103384136
}

{
  "tool_name": "shell",
  "tool_input": {
    "command": "cd /workspace/work && cat > ct.py <<'EOF'\nimport json,urllib.request,csv\nbase=\"https://clinicaltrials.gov/api/v2/studies\"\nparams=\"?filter.advanced=AREA%5BStartDate%5DRANGE%5B2026-08-28%2C2026-09-11%5D&query.term=AREA%5BPhase%5DPHASE3%20AND%20AREA%5BStudyType%5DINTERVENTIONAL%20AND%20AREA%5BOverallStatus%5DRECRUITING&pageSize=50&fields=NCTId%2CBriefTitle%2CCondition%2CInterventionName%2CLeadSponsorName%2CEnrollmentCount%2CStartDate%2CPhase%2CLocationCity%2CLocationCountry\"\nrows=[];tok=None\nwhile True:\n    u=base+params+(f\"&pageToken={tok}\" if tok else \"\")\n    d=json.load(urllib.request.urlopen(u))\n    for s in d[\"studies\"]:\n        p=s[\"protocolSection\"]\n        locs=p.get(\"contactsLocationsModule\",{}).get(\"locations\",[])\n        countries=sorted({l.get(\"country\",\"\") for l in locs})\n        cities=[l.get(\"city\",\"\") for l in locs]\n        rows.append({\n         \"NCT\":p[\"identificationModule\"][\"nctId\"],\n         \"Start\":p[\"statusModule\"][\"startDateStruct\"][\"date\"],\n         \"Phase\":\"/\".join(p[\"designModule\"][\"phases\"]),\n         \"Condition\":\"; \".join(p[\"conditionsModule\"][\"conditions\"][:3]),\n         \"Intervention\":\"; \".join(i[\"name\"] for i in p.get(\"armsInterventionsModule\",{}).get(\"interventions\",[])[:4]),\n         \"Sponsor\":p[\"sponsorCollaboratorsModule\"][\"leadSponsor\"][\"name\"],\n         \"Enrollment\":p[\"designModule\"].get(\"enrollmentInfo\",{}).get(\"count\"),\n         \"Sites\":len(locs),\n         \"Countries\":\", \".join(countries),\n         \"ExampleCities\":\", \".join(cities[:5]),\n         \"Title\":p[\"identificationModule\"][\"briefTitle\"][:150],\n        })\n    tok=d.get(\"nextPageToken\")\n    if not tok: break\nrows.sort(key=lambda r:(r[\"Phase\"]!=\"PHASE3\", -(r[\"Enrollment\"] or 0)))\nwith open(\"ct_phase3_recruiting.csv\",\"w\",newline=\"\") as f:\n    w=csv.DictWriter(f,fieldnames=list(rows[0].keys()));w.writeheader();w.writerows(rows)\nprint(len(rows), sum(1 for r in rows if r[\"Phase\"]==\"PHASE3\"))\nfor r in rows[:12]: print(r[\"NCT\"],r[\"Phase\"],r[\"Enrollment\"],r[\"Sponsor\"],\"|\",r[\"Condition\"],\"|\",r[\"Countries\"][:60])\nEOF\npython3 ct.py"
  },
  "dispatch_id": "toolu_01HvDcceCGWpyGUtYDiA9R3C",
  "parent_dispatch_id": "",
  "handle": "",
  "panel_kind": "shell"
}

{
  "tool_name": "shell",
  "dispatch_id": "toolu_01HvDcceCGWpyGUtYDiA9R3C",
  "status": "running",
  "result": null,
  "error": "",
  "elapsed": null,
  "fields": {
    "progress": {
      "message": "",
      "metadata": {
        "browser_chain": false,
        "command": "cd /workspace/work && cat > ct.py <<'EOF'\nimport json,urllib.request,csv\nbase=\"https://clinicaltrial...",
        "phase": "starting"
      }
    },
    "status": "running",
    "updatedAt": 1789169522684
  }
}

{
  "tool_name": "shell",
  "dispatch_id": "toolu_01HvDcceCGWpyGUtYDiA9R3C",
  "status": "completed",
  "result": "44 38\nNCT07743580 PHASE3 2000 Shionogi | SARS-CoV-2 | Bulgaria, Japan, United States\nNCT07493304 PHASE3 1600 Regeneron Pharmaceuticals | Venous Thromboembolism (VTE) | South Korea, United States\nNCT07751133 PHASE3 1500 University College, London | Prostate Cancer; mHSPC; mCRPC | United Kingdom\nNCT07679360 PHASE3 1000 Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Triple Negative Breast Cancer | China\nNCT07807865 PHASE3 900 Intra-Cellular Therapies, Inc. | Generalized Anxiety Disorder | United States\nNCT07212998 PHASE3 750 Jason Sperry | Burn Injury; Thermal Burn | United States\nNCT07564141 PHASE3 688 Genmab | Platinum-Sensitive Ovarian Cancer; Ovarian Cancer | United States\nNCT07285239 PHASE3 500 PrECOG, LLC. | Multiple Myeloma | United States\nNCT07804186 PHASE3 450 IDEAYA Biosciences | Uveal Melanoma | Canada\nNCT07768345 PHASE3 440 Pfizer | Respiratory Syncytial Virus (RSV) | United States\nNCT07623200 PHASE3 426 Incyte Corporation | Essential Thrombocythemia | Australia, Austria, Belgium, Canada, Czechia, France, German\nNCT07640789 PHASE3 418 Sichuan Baili Pharmaceutical Co., Ltd. | Non-small Cell Lung Cancer Stage III | China\n",
  "error": "",
  "elapsed": 0.790398234
}

{
  "tool_name": "upload_file",
  "tool_input": {
    "path": "/workspace/work/ct_phase3_recruiting.csv"
  },
  "dispatch_id": "toolu_01XAVWSsuoP8eWnhEeA4gf8k",
  "parent_dispatch_id": "",
  "handle": "",
  "panel_kind": ""
}

{
  "tool_name": "upload_file",
  "dispatch_id": "toolu_01XAVWSsuoP8eWnhEeA4gf8k",
  "status": "completed",
  "result": {
    "artifact_keys": [
      {
        "attachment_url": "s3://sessions/80fa523d-a68f-45ae-b973-06bd08fb1b40/uploads/0abb4d08-195/ct_phase3_recruiting.csv",
        "path": "ct_phase3_recruiting.csv",
        "s3_key": "sessions/80fa523d-a68f-45ae-b973-06bd08fb1b40/uploads/0abb4d08-195/ct_phase3_recruiting.csv"
      }
    ],
    "message": "File displayed to the user.",
    "status": "success"
  },
  "error": "",
  "elapsed": 0.362200294
}

{
  "tool_name": "send_message",
  "tool_input": {
    "final": true,
    "in_response_to": "a0695b31",
    "message": "44 interventional studies with a Phase 3 component started recruiting between Aug 28 and Sep 11, 2026 (38 pure Phase 3, 6 Phase 2/3). The attached CSV has all 44 with condition, interventions, sponsor, enrollment, site count and countries. The largest:\n\n| Condition | Intervention | Sponsor | Enrollment | Locations |\n|---|---|---|---|---|\n| COVID-19, high risk ([NCT07743580](https://clinicaltrials.gov/study/NCT07743580)) | Secutrelvir vs placebo | Shionogi | 2,000 | US (FL, OH), Bulgaria, Japan |\n| Cancer-associated VTE ([NCT07493304](https://clinicaltrials.gov/study/NCT07493304)) | REGN7508 vs apixaban | Regeneron | 1,600 | US (NY, FL, TX), South Korea |\n| Metastatic prostate cancer ([NCT07751133](https://clinicaltrials.gov/study/NCT07751133)) | ARPI dose optimization (abiraterone, enzalutamide, others) | University College London | 1,500 | UK, Manchester |\n| Residual triple-negative breast cancer ([NCT07679360](https://clinicaltrials.gov/study/NCT07679360)) | Trastuzumab rezetecan + adebrelimab | Suzhou Suncadia | 1,000 | China, Beijing |\n| Generalized anxiety disorder ([NCT07807865](https://clinicaltrials.gov/study/NCT07807865)) | ITI-1284 | Intra-Cellular Therapies | 900 | US, Los Angeles |\n| Metastatic urothelial carcinoma ([NCT07815665](https://clinicaltrials.gov/study/NCT07815665), Ph2/3) | Ivonescimab + enfortumab vedotin vs pembrolizumab + EV | Summit Therapeutics | 800 | US: Phoenix, LA, DC, Jacksonville, Rochester, Nashville, Spokane |\n| Severe burn injury ([NCT07212998](https://clinicaltrials.gov/study/NCT07212998)) | Early plasma resuscitation vs standard care | Univ. of Pittsburgh | 750 | US, Pittsburgh |\n| Platinum-sensitive ovarian cancer ([NCT07564141](https://clinicaltrials.gov/study/NCT07564141)) | Rina-S +/- bevacizumab vs chemo | Genmab | 688 | US: Danbury CT, Waukesha WI |\n| Newly diagnosed multiple myeloma ([NCT07285239](https://clinicaltrials.gov/study/NCT07285239)) | Belantamab mafodotin or daratumumab + VRd | PrECOG | 500 | US, La Crosse WI |\n| Essential thrombocythemia ([NCT07623200](https://clinicaltrials.gov/study/NCT07623200)) | INCA033989 vs best available therapy | Incyte | 426 | ~170 sites across US, EU, Australia, Japan, Korea, Canada |\n| Uveal melanoma, adjuvant ([NCT07804186](https://clinicaltrials.gov/study/NCT07804186)) | Darovasertib + crizotinib | IDEAYA | 450 | Toronto, Canada |\n| RSV revaccination, immunocompromised ([NCT07768345](https://clinicaltrials.gov/study/NCT07768345)) | RSVpreF vaccine | Pfizer | 440 | US: Los Angeles, Decatur, Rochester |\n\nNote: some entries list only a start month (September 2026), so the 14-day window includes them by month."
  },
  "dispatch_id": "toolu_013PUHyd3EMRcLm5LYiL2RuB",
  "parent_dispatch_id": "",
  "handle": "",
  "panel_kind": ""
}